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1. INTRODUCTION
The metabolic disease diabetes mellitus and its incidents keeps on increasing in our 
nation at a fastest rate. So, that as many as 50 million people are at present suffering from type II 
diabetes and We the health providers have to face this challenge. Exactly for this particular 
reason, I have choosen this project work entitled   Comparetive study of Antidiabetic & 
Hypolipidemic activity of Crateva magna root & Eugenia jambolana seed and its combination in 
rats  . Diabetes is one of the most talked about diseases across the world and especially in India, 
yet the awareness about the same do not exist among the people sufficiently. With the country 
having the highest number of diabetic patients in the world, the sugar disease is posing an 
enormous health problem today in our nation. India , often known as the diabetes capital of the 
world, has been witnessing an alarming rise in the incidence of diabetes according to the 
International Journal of Diabetes in Developing Countries. According to a World Health 
Organization (WHO) fact sheet on diabetes, an estimated 3.4 million deaths are caused due to 
diabetes.
The WHO also estimates that 80 per cent of diabetes deaths occur in low and middle-
income countries and projects that such deaths will double between 2016 and 2030. It has been 
further estimated that the global burden of type-2 diabetes is expected to increase to 438 million 
by 2030 from 285 million people (recorded in 2010). Similarly, for India this increase is 
estimated to be 58%, from 51 million people in 2010 to 87 million in 2030. But debates, 
discussions and deliberations aside, the fundamental thing is to know what exactly is diabetes.
Diabetes mellitus is a group of chronic diseases characterized by high levels of blood 
glucose caused by body  s inability to produce or the body  s cells unresponsiveness to insulin. 
Diabetes can lead to blindness, kidney failure, nerve damage and blood vessels. It plays an 
important factor in accelerating the hardening and narrowing of arteries (atherosclerosis), leading 
to strokes, coronary heart disease.
Diabetes is one of the first diseases described with an Egyptian manuscript from 1500BC, 
mentioning   too great emptying of urine  .  The described cases are believed to be of type 1 
Diabetes.  Indian physicians around the same time identified the disease and classified it as 
madhumeha or honey urine noting that the urine would attract ants.  The term   Diabetes   or   to 
pass through   was first used in 230 BC by the Greek Appollonius of Memphis.  The disease was 
rare during the time of the Roman empire with Galen commenting that he had only two cases 
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during the time of the Roman empire with Galen commenting that he had only two cases during 
the career.  Type 1 and type 2 Diabetes where identified as separate conditions for the first time 
by the physicians Sushrutha and Charaka in 400-500 AD with type 1 associated with youth and 
type 2 with overweight.  The term   Mellitus   or   from honey   was added by the Britain John 
Rolle in the late 1700s to separate the condition  from Diabetes insipidus which is also associated 
frequent urination.  Until early part of 20th century there was no effective treatment for Diabetes.  
Canadians   Frederick Banting   and Charles Best developed insulin in 1921 and 1922.  This was 
followed by developed of long lasting insulin NPH in 1940s. 1,2
According to World Health Organisation79
∑ 346 million people in world are suffering with Diabetes.
∑ In 2004, it is estimated that 3.4 million people died from consequences of high blood 
sugar.
∑ More than 80% of Diabetes deaths occur in low and middle income countries.
∑ WHO projects that Diabetes deaths will double between 2005 and 2030.
∑ Healthy diet, regular physical activity, maintaining a normal body weight and avoiding 
tobacco use can prevent or delay the onset of type 2 diabetes. 
1.1 HERBAL DRUGS IN DIABETES TREATMENT
India is the largest producer of medicinal herbs and is called as botanical garden of the world. 
Ayurveda, Unani, Siddha and Folk (also called tribal) medicines are the major systems of Indian 
medicines. Among these systems, Ayurveda is most developed and widely practiced in India. A 
number of plants have been described in Ayurveda and other traditional medicine for the 
treatment of diabetes. Isolation of the main compounds from the active extract is a crucial step in 
all research activities for developing a novel phytomedicine for diabetes mellitus.
A number of plants have been described in Ayurveda and other traditional medicine for the 
treatment of Diabetes.  In Ayurveda Diabetes is described as   Madhumeha  .  In developing 
countries 80 % of populations are using traditional medicine in primary medical problems.  Drug 
Metformin (a biguanide) is a derivative of an active natural product, galagine a biguanide isolated 
from the plant Galega officinalis L., which was used to relieve the intense urination in diabetic 
people.  Even the root juice of Helicteris isora Linn (Family-Sterculaceae) is claimed to be useful 
in Diabetes, emphysema and a favourite cure for snake bite.  Despite considerable progress in the 
management of Diabetes by conventional drugs, the search for natural antidiabetic plant products 
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as alternative therapy for progressing .  Many medicinal plants have been shown experimental or 
clinical antidiabetic activity and that have been used in traditional systems of medicine.  Plants 
such as M. Charantia, Eugenia Jambolona, Mucuna precriens, Murraya Koeingii and Brassica 
have found to have anti diabetic activity.  All plants have shown varying degree of hypolipidemic 
and antihyperglycemic activity.  In the recent years more than 500 herbal medicines have been 
reported to possess anti-diabetic property.3-8
An ethno botanical survey of semi-structured questionnaire of medicinal plants in five districts of 
Nigeria reputed for the treatment of Diabetes have been reported.  The principal antidiabetic 
plants included Vernonia amygdalina and Morinda lucida.  The data base maintaining the record 
of medicinal plants having hypoglycemia or antidiabetic has been reported on 2009.  The herbal 
drugs with antidiabetic activity are yet to be commercially formulated as poly herbal formulation, 
even though they have been acclaimed for their therapeutic properties in the traditional systems 
of medicine.
The management of diabetes without any side effect is still a challenge to the medical 
system.  Herbal drugs are prescribed widely because of their effectiveness, fewer side effects and 
relatively low cost.  Wide array of plant derived active principles have demonstrated anti diabetic 
activity.  The main active constituents of these plants include alkaloids, glycosides, steroids, 
carbohydrates, glycopeptides, terpenoids, amino acids and inorganic ions.  These affect various 
metabolic cascades, which directly or indirectly affect the level of glucose in the humanbody.9
World Health Organisation recommendations (WHO 1980) on the use of alternative 
medicines for treating diabetes mellitus provide an impetus for research in this area.  Currently, 
the focus of research in diabetes includes discovering newer anti diabetic agents as well as 
isolating the active compounds from herbal sources that have been documented to have anti
diabetic properties as have been described in ancient texts.10
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1.1.  The scientifically documented list of medicinal plants exhibiting antidiabetic activity.
Table no: 1. List of medicinal plants exhibiting antidiabetic activity
Name of the 
plant
Family Parts used Type of the 
plant extract
Animal 
model
Reference
Aloe vera Asphodelaceae Leaf, gel 
extract
Ethanolic Rats (alx) 26
Artemisia 
sphaerocephala 
krasch
Astaraceae Seeds Aqueous Rats (alx) 27
Artanema 
sesamoides
Scophuilariaceae Aerial 
parts
Methanolic Rats (stz) 28
Cassia kleinii Caesalpiniaceae Leaf, roots Aqueous, 
Ethanolic
Rats (alx) 29
Cassia glauca 
Linn.
Caesalpiniaceae Leaves Petroleumether, 
chloroform, 
acetone, 
methanolic
Rats (stz) 30
Coctus pictus Zingiberaceae Leaves Aqueous Rats (stz) 31
Ficus hispida Moraceae Bark Ethanolic Rats (alx) 32
Lycium 
barbarum
Solanaceae Fruits Aqueous Rats (alx) 33
Eugenia 
jambolona
Myrtaceae Fruits Aqueous, 
ethanolic
Rats (alx) 34
Ficus Moraceae Leaves Ethanolic Rats (alx) 35
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microcarpa
Phyllanthus 
rheedii
Euphorbiaceae Whole 
plant
Ethanolic Rats (stz) 36
Justicia 
beddomei
Acanthaceaea Leaves Chloroform, 
ethanolic
Rats (alx) 37
Nymphaea 
stellata
Nymphaeaceae Flowers Hydro-
ethanolic
Rats (alx) 38
Ichonocarpus 
fructescens
Apocynaceae Roots Aqueous Rats (stz) 39
Salvadora 
oleoides
Salvadora 
oleoides
Stems, 
leaves
Ethanolic Rats (alx) 40
Adhatoda 
zeylanica 
Medic
Acanthacaeae Leaves Hexane, 
Methanolic
Rats (alx) 41
Berberis 
aristata D.C
Berberidaceae Roots Ethanolic, 
chloroform, 
petroleum ether
Rats (alx) 42
Gymnema 
sylvestre
Asclepiadaceae Leaves Aqueous Rats (alx) 43
Tinospora 
cordifolia Willd
Menipermacadeae Stem Aqueous and 
ethanolic
Rats (stz) 44
Neolamarckia 
cadamba
Rubiaceae Stem, Bark Ethanolic Rats (alx) 45
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Barleria 
prionitis
Acanthaceae Leaves, 
roots
Ethanolic Rats (alx) 46
Pongamia 
pinnata
Leguminosae Leaves Ethanolic, 
Chloroform
Rats (alx) 47
Vinca rosea Apocynaceae Leaves Dichloro-
methane and 
methanolic
Rats (alx) 48
Vinca rosea Apocynaceae Whole plant Ethanolic Rats (alx) 49
Indigofera 
pulchra
Papilionaceae Leaves Ethyl acetate, n-
butanol
Rats (alx) 50
Sarcococca 
saligna
Buxaceae Whole plant Petroleum ether, 
ethyl acetate
Rats (stz) 51
Momordica 
charantia
Cucurbitaceae Fruits, 
leaves
Ethanolic Rats (alx) 52
Holostemma 
ada-kodien
Asclepiadaceae Root Ethanolic Rats (alx) 53
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2. SCOPE OF THE PRESENT STUDY
Diabetes mellitus is a group of metabolic disorders characterized by hyperglycemia. The 
hyperglycemia results from defects in insulin secretion, insulin action or both. The chronic 
hyperglycemia of Diabetes is associated with specific chronic complications resulting in damage 
to or failure of various organs, notably the eyes, kidneys, heart and blood vessels.
Diabetes mellitus is set to become one of the worlds biggest health problems owing to the 
projected increase in new cases. In India, the prevalence rate of Diabetes is estimated to be 1-5%. 
Complications are the major cause of morbidity and mortality in Diabetes mellitus.
So many herbal drugs are used in the treatment of Diabetes mellitus. Crateva magna is 
having the anti diabetic activity. As per the literature review still no anti diabetic activity has been 
reported on this plant. In review of literature Crateva nurvella has shown antidiabetic activity. 
So, the Crateva magna also has come from the same family. Hence, this study has been taken to 
explore the antidiabetic, hypolipidemic potential of Crateva magna root on streptozotocin 
induced Diabetes in Wistar albino rats and Eugenia jambolana seed has well known for its anti 
diabetic activity.
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For the present study I have selected 3 samples of herbal drugs for screening of antidiabetic 
activity,
1. Crateva magna root.
2. Eugenia jambolana seed.
3. 1:1 Combination of Crateva magna root and Eugenia jambolana seed.
2.1 PLANT DESCRIPTION
1. Crateva magna
Botanical Name : Crateva magna
Family                  : Capparaceae
Trade Name        :Three Leaved   Caper, Garlic PearTree
Vernacular Names
English : Three Leaved   Caper, Garlic PearTree
Tamil Name : Mavilangam, Varanam
Malayalam : Neermathalam, Neerval, Mavulangam
Hindi Name : Barun, Barna
Sanskrit Name : Varuna
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Taxonomical Classification
Kingdom   : Plantae
Phylum     : Tracheophyta 
Class          : Magnoliopsida
Order        : Brassicales
Family       : Cappraceae
Genus       : Crateva
Species     : Crateva magna
Scientific Name : Crateva magna
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Picture No : 1 Flowers of Crateva magna
Picture No : 2 Whole Plant of Crateva Magna
Comparetive study of Antidiabetic and hypolipidemic activity of Crateva magna root & Eugenia jambolana seed and 
its combination in rats . 
Department	of	Pharmacology,	Cherraan  s	College	of	Pharmacy,	Coimbatore Page	11
Botanical Description :
A small much branched deciduous tree. Leaves 3-foliolate; leaflets 5-15 cm long, ovate, 
lanceolate or obovate, acute. Flowers many, in dense terminal corymbs; petals nearly 2.5 cm 
long, greenish white; stamens longer than the petals. Fruit a globose or ovoid, woody berry. 
Trees, to 10 m high, bark 2-3 mm thick, surface grey, smooth, longitudinally wrinkled; blaze dull 
yellow. Leaves digitately trifoliate, alternate, estipulate; rachis 4-12 cm long, slender, grooved 
above, glabrous; petiolule 4-7 mm long, slender; leaflets 10-20 x 3.5-6 cm, unequal, ovate, ovate-
lanceolate or broadly elliptic, base acute, or subacute, apex acute or acuminate, margin entire, 
glabrous, coriaceous; lateral nerves 9-15 pairs, slender, parallel, prominent, intercostae reticulate, 
faint. Flowers bisexual, creamy white, in terminal corymbs; pedicel to 5 cm long; sepals 4, 3 mm 
long, free, oblong, adnate to the lobed disc; petals 4, ca. 2 cm long, creamy white, often tinged 
with purple, long-clawed, obovate; disc incurved, nectariferous; stamens many, free, longer than 
the petals, inserted at the base of gynophore; anthers basifixed, filaments spreading; gynophore 4-
5 cm long at anthesis, slender; ovary superior, ellipsoid, 1-[2]-celled, ovules many; stigma 
sessile, capitate. Fruit a berry, globose or ovoid, yellowish-grey, rind woody, scurfy, 4-5 x 2.5-3.5 
cm; seeds brown, embedded in pulp.
Biology
Crateva magna is small wild or cultivated tree native to india, China, Bangaladesh, Sri Lanka, 
Burma, Thailand, Campodia, Indonesia and Malaysia. Its often found along streams also in dry, 
deep boulder formations in Sub Himalayan tracts.
Habit : Tree
Flowering & Fruiting : March   April
Habitat : River banks semi evergreen forests
Distribution : Indo-malaysian, China
Aquatic : No
Epiphyte(s) : No
Flower Colour : Creamy White
Weed : No
Monocot/Dicot : Dicotyledonous Plants
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Chemical Constituents
Stem bark of the plant contains saponins, flavonoids, sterols and glucosilinates and ceryl alcohol, 
friedelin, cadabicine, diacetate, lupeol, betulinic acid and diosgenin. Fruits contain glycocaparin, 
ß-sitosterol, triacontane, triacontanol, cetyl and ceryl alcohols. Leaves contain l-stachydrine. Root 
bark contains rutin, quercetin, lupeol, varunol and ß-sitosterol.
It also contains lauric, stearic, undecylic, oleic and linolenic acids and a new triterpene alcohol  
lupa-21, 20(29)dien-3ß-ol. Presence of alkaloids have been reported in bark and stem. These 
alkaloids showed antimicrobial activities. Fruit contains cetyl alcohol, ceryl alcohol, triacontane, 
triacontanol, ß-sitosterol and glucocapparin (Ghani, 2003).
Medicinal uses
The dried bark is used raw drug in traditional systems of medicine in India such as 
Ayurveda, siddha etc. The decoction of bark is internally administered to cure diseases like renal 
calculi, dysuria, helminthiasis, inflammations and abscesses. The decoction exhibits actions like 
carminative, laxative, thermogenic, diuretic, lithontriptic, expectorant and demulcent.[4] The leaf 
and stem bark have been evaluated for their antioxidant activity and inhibition of key enzymes 
relevant to hyperglycemia.[5] Leaves are stomachic, tonic, rubefacient and febrifuge; used in
rheumatism. Flowers are astringent and cholagogue. A couple of buds pounded with salt are 
taken before meals to promote the appetite. The fruits are laxative. Roots and bark are laxative, 
lithontriptic, anthelmintic, expectorant; promote appetite and increases biliary secretion.
Bark is demulcent, stomachic and laxative; useful in fever, vomiting and symptoms of 
gastric irritation; especially useful in cases of kidney and bladder stones. Juice of the bark is 
given to women as a contraceptive after childbirth. Bark is bitter and poisonous. Water soluble 
fraction of alcoholic extract is spasmolytic on animal and human uteri and cholinergic on smooth 
muscles of animals. Petrolium ether extract is anti-inflammatory against different types of 
inflammation. Root extract is antibacterial against Gram +ve and Gram   ve bacteria. Alcoholic 
extract of stem is antibacterial against E. coli. Plant inhibited phosphatic stone formation in rats 
(Asolkar et al., 1992).
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2. Eugenia jambolana 
Botanical Name : Eugenia jambolana
Family                  : myrtaceae
Trade Name        : jaman
Vernacular Names
English : jaman
Tamil Name : naval
Gujarati : jambu
Hindi Name : jamun
Sanskrit Name : jambu
Kannada Name : Ama-Phala, Jambunerale, Nayenerale
Marathi Name : Jambhul
Telugu Name : Goyya   Pandu, Jam-Pandu
Taxonomical Classification
Kingdom   : Plantae
Phylum     : Tracheophyta
Class          : Magnoliopsida
Order        : Myrtales
Family       : Myrtaceae
Genus       : Eugenia
Species     : jambolana
Scientific Name : Eugenia jambolana
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Picture No 3: Eugenia jambolana Whole Tree
Picture No 4: Fruits of Eugenia jambolana
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Biology
It is an ever green tree that attains a height of 100 feet and can be 12 feet broad. Leaves 3 to 6 
inch long and 2 to 3 inch broad. These are ovate shape and are shiny in texture. Flowers are 
light green to white in colour. Fruits are ½ to 1½  inch long and oval in shape. When the fruit 
is raw it is green in colour when it is ripe it becomes red or purple in colour. The fruit 
contains seed that is about 1 to 2 cm in length. Flowers are born in early summers and fruits 
in autumn.
Chemical Constituents
Fruits has contains moisture that is 83.7%, protein 0.7%, fat 0.3%, carbohydrate 14%, 
minerals, vitamin A,B,C, melic acid, oxalic acid, garlic acid, tannin, a aromatic oil and a blue 
colour substance which is cyaniding diglycosides. Besides it contains tannins 19%, elgic acid, 
gallic acid 1 to 2% and glycoside named jamboline. It also contains starchand light yellow 
coloured aromatic oil which is 0.05%. Bark contains betulenic acid, beta sitosterol, elagic 
acid and mirisetin.
Pharmacological Use
It is useful in ailments caused by kapha and pitta. It has a cohesive action. Because of cool 
nature it is helpful in skin related ailments and suppresses burning sensation occurring in the 
body. It helps proper digestion in  the body. It helps in curbing infection in the body. It is an 
antidiuretic in nature and reduces the sugar levels in blood and urine.
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3. Review of Literature
3.1. Crateva magna
1. Sovan Pattanaik* and et al, School of Pharmaceutical Sciences, Siksha 
  O  Anusandhan University, Bhubaneswar, Odisha, India.  Wound healing activity of methanolic 
extract of the leaves of Crateva magna and Euphorbia nerifolia in rats Abstract Crataeva magna
and Euphorbia nerifolia have been shown to possess hepatoprotective activity and antioxidant 
property. The present works with these plants were undertaken with the premise that the drug 
promoting hepatoprotective activity and radical scavenging property could have effect on wound 
healing also. The wound healing property of the methanolic extract of the leaves of Crataeva 
magna (CNM) and Euphorbia nerifolia (ENM) were chosen to investigate in excision and 
incision wound models. The methanolic extracts of the two plants at the dose of 500 mg/kg/day 
by topically applying method. Healing was assessed by the rate of wound contraction, time until 
complete epithelialization, incision breaking strength, estimation of hydroxyproline and 
histopathological parameters. Complete wound contraction was shown by both the plants in the 
study period. In excision and incision wound models, all the test drugs showed significant (P < 
0.001) wound healing activities compared to the control. Moreover the CNM was found to 
possess significant wound healing activities than the ENM and had been observed to have 
equipotent wound healing activity as of the standard drug Framycetin.
2. Atanu Bhattacharjee and et al, Department of Pharmacognosy, NGSM Institute of 
Pharmaceutical Sciences, Deralakatte, Mangalore, Karnataka, India Phytochemical and ethno-
pharmacological profile of Crataeva nurvala Buch-Hum (Varuna).
Crataeva nurvala Buch-Hum (Varuna) is well known traditional Indian medicinal to treat various 
ailments in particular urolithiasis. During last two decades, numerous ethno-pharmacological and 
scientific reports have been cited in the literature to support its multidirectional therapeutic 
potential. The plant is rich in alkaloids, Saponins, triterpenes, tannins, flavanoid glycosides, 
glycosinolates and phytosterols. The review emphasizes primarily on folkloric uses, biologic 
activities of isolated compounds, pharmacological activities of the extracts, clinical studies and 
safety profile of crateva nurvella to provide a comprehensive data for researchers to hit upon new 
chemical entity responsible for its claimed traditional uses. 
3. Shashikanta behera and et al Department of Botany, Ravenshaw University, Cuttack, 
Odisha, India. Phytochemical analysis of the leaf, flower, and bark extracts was done using 
various solvent by standard methods as described by Harborne (1973). Six different extracts each 
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for leaf, flower, and bark were screened. Saponins were present in all the extracts of leaf, flower, 
and bark, whereas not a single extract showed the presence of steroids. Five extracts of flower 
and four extracts of leaf and bark indicated the prevalence of flavonoids. Similarly, four extracts 
of bark and three extracts of leaf and flower showed the incidence of tannins. Terpenoids 
occurred only in the aqueous extracts of leaf and flower, whereas alkaloids were found only in 
two and one extract(s) of leaf and bark, respectively. Phenolic compounds were not found in any 
of the bark extracts, but three and two extracts of leaf and flower showed their presence.
4. Sridhar N and et al, Antinephrolithiatic effect of Crateva magna Lour DC root on 
ethylene glycol induced lithiasis. The extract of Crateva magna was screened for 
antinephrolithiatic activity in male wister rats were summarised based on the ionic changes in 
both urine and serum. The present study was carried out to evaluate Antinephrolitiatic activity in 
rats using 0.75% ethylene glycol in drinking water was given orally for 28 days. The plant 
Crateva magna is used in analgesic, antiprotozoal, hypoglycaemic, anti-inflammatory, 
hypotensive, anti spasmodic purposes. The aqueous extract of leaves of Crateva magna results 
maximum yield value than that of petroleum ether extract, Chloroform extract and alcohol extract 
through successive maceration process. The aqueous extract of leaves of Crateva magna showed 
maximum control of lithiasis in wister rats. Urinary volume was increased in nephrolithiatic as 
well as drug treated rats. Increased urinary excretion of calcium, oxalate, uric acid, phosphates 
and protein in nephrolithiatic rats was bought down significantly by the administration of Crateva 
magna. Decreased magnesium excretion in hyperoxaluric rats was normalized with respect to 
calcium oxalate and other crystallizing salts such as uric acid, which may induce epitaxial 
deposition of calcium  oxalate. Simultaneous treatment with the extract reduced calcium and 
oxalate ion concentration in urine confirming stone inhibitory effect. In Ethylene glycol induced 
nephrolithiasis,  the nephrolithisis was significantly reduced and the stone formation was 
normalized by administration 200 mg/kg and 400 mg/kg dose orally and the property was 
comparable to the standard drug. This study has extablished the antinephrolithiatic activity of 
Crateva magna and thus, justifies the uses of this plan lithiasis.
5. Amresh Panda and et al, Hepatoprotective activity of leaves of Crataeva magna in different 
types of hepatotoxic rat models. Crataeva magna (Lour.) DC belonging to family Capparaceae is 
a high-value medium sized deciduous medicinal tree of tropical climate found in tropical regions 
of the world and also grows almost all over India, especially in the semiarid regions. The present 
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investigation is designed to conduct phytochemical screening of Crataeva magna leaves after 
each successive extraction with petroleum ether, chloroform, methanol and water followed by its 
hepatoprotective activity study. Three different types of models used to examine the in vivo 
hepatoprotective activity of the above said extract were carbon tetrachloride, ethanol and 
paracetamol induced hepatotoxicity in rats and compared with silymarin (20 mg/kg) as
reference standard. Phytochemical screening revealed the presence of carbohydrates, phenolic 
compounds, tannins, flavonoids, saponins and fixed oils in the aqueous extract of the 
Crataeva magna leaves. Two way analysis of variance study of the estimated biochemical 
parameters to illustrate, aspartate aminotransferase, alanine amino transferase and alkaline 
phosphatase were revealed that there is significant difference (p-value < 0.001) exists 
between the different treatment groups. Severe hepatic lesions induced by carbon 
tetrachloride, ethanol and paracetamol were significantly lowered after the administration of 
CM 200 mg/kg to the respective control groups (carbon tetrachloride > paracetamol > 
ethanol) which was also evident from the histopathological study of liver sections. 
6. Sridhar N and et al, In-vitro antioxidant activity of Crataeva magna lour. Dc bark extract. The plant 
Crataeva magna belonging to family Capparaceae is used in anti spasmodic, hypotensive, anti-
inflammatory, hypoglycemic, anti protozoal, analgesic purposes. The present study was carried out to 
evaluate appropriate animal model. The antioxidative potential of different solvent extracts of Crataeva 
magna were evaluated using 1,1-Diphenyl-2-Picrylhydrazyl (DPPH), 2,2′-Azino-Bis(3-
ethylbenzthiazoline-6-Sulphonic acid) (ABTS), superoxide radical, hydroxyl radical, nitric oxide radical 
scavenging activities and lipid peroxidation inhibition assay. Among those solvent extracts, ethanolic 
extract of C. magna exhibited highest level of antioxidant activities. The ethanolic extract also inhibited 
H2O2 mediated haemolysis and lipid peroxidation in human RBC. 
7. S. Pattanaik and et al, Evaluation of hepatoprotectve activity and isolation of 2-(3, 4-Dihydroxy 
Phenyl)-7-Hydroxy-3-(2-Hydroxy Ethoxy) 4-H-chromen-4one from column fractions of leaves of the 
extract of Crataeva magna. Nature is only source of hepatoprotective drugs in modern medicine to 
prevent and treat drug-induced liver damage. The alcoholic extract of fresh leaves of the plant Crataeva 
magna, previously reported for its hepatoprotective activity was fractionated into three parts to chemically 
identify the most potent bioactive fraction. The current study was designed to evaluate the 
hepatoprotective activity, isolation and characterization property of effective column fractions of the 
leaves of the plant Crataeva magna. The hepatopreventive effect of the column fractions (F1, F2 and F3) 
of the leaves of the plant were evaluated by measuring the levels of serum liver damage marker enzyme 
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such as alanine transaminase, aspartate transaminase, alkaline phosphatase, total and direct bilurubin. As 
per the result, since the F3 fraction of the extract showing out the significant reduction in the elevated 
serum level which can be compared with the standard drug silymarin therefore, phytochemical 
investigation of the F3 fractions led to the identify the structure of the flavonoid compound which was 
established by spectroscopic methods (UV, IR, 1H NMR, 13C NMR and EI-MS) as 2-(3, 4-Dihydroxy 
Phenyl)-7-Hydroxy-3-(2-Hydroxy Ethoxy) 4-H-Chromen-4one. 
8. Chidambaram K and et al, Antipyretic activity of Crateva magna bark on Tab-Vaccine 
induced pyrexia Objective: Crataeva magna is a potent medicinal plant in the Indian systems of 
medicine. Traditionally used for inflammation, fever, arthritis, bronchitis, urinary calculi and 
cough. The objective of the present work was to study the antipyretic activity of plant Crataeva 
magna (Lour.) DC belonging to family Capparaceae. Materials & Methods: In the present study 
the alcoholic extracts of the bark of Crataeva magna were studied for their antipyretic activity by 
TAB (Typhoid) vaccine-induced pyrexia in rabbits. Result: In TAB vaccine-induced fever, the 
fever was significantly reduced and the body temperature was normalized by administration of 
200 and 400 mg/kg dose orally and the property was comparable to the reference drug. 
Conclusion: This study has established the antipyretic activity of Crataeva magna and thus, 
justifies the anecdotal, folkloric and ethnomedical uses of this plant for fever.
9. Monnanda S Nalini and et al, Fungal endophytes from the three-leaved caper, Crataeva 
magna (Lour.) DC. (Capparidaceae) Fungal endophytes were isolated from Crataeva magna, a 
medicinal plant growing along the streams and rivers, constituting riparian vegetation in 
Karnataka, southern India. Fresh bark and twig pieces were used for the isolation using standard 
methods. Ninety-six endophytic fungal isolates were isolated from 800 bark and twig segments. 
Mitosporic fungi represented as a major group (85%) followed by zygomycetes (10%) and 
ascomycetes (5%). Bark samples contained more endophytes than twig samples. Verticillium, 
Nigrospora oryzae and Fusarium verticilloides were the dominant fungal endophytes. 
10. Nishritha Bopana and et al, In vitro regeneration of clonally uniform plants of Crataeva
magna: A high value medicinal tree by axillary branching method. Crataeva magna (Lour.) DC 
(synonym C. nurvala) is a high-value Indian medicinal tree. The multiple uses of C. magna have 
resulted in its over-exploitation. Erratic seed germination combined with destructive harvesting 
and habitat destruction in the form of deforestation has added to the enormity of the problem. 
Therefore, the need for conservation of this plant is vital. Development of an efficient 
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micropropagation protocol will play a significant role in meeting the requirement of quality 
planting material for commercial cultivation thereby conserving the species in its natural habitat. 
In the present study, shoot multiplication was achieved by culturing single node segments derived 
from a field grown tree on Murashige and Skoog  s (MS) medium supplemented with 2.66μM 
N6-benzyladenine, 1.39μM Kinetin (Kn), 0.57μM indole-3-acetic acid (IAA), 3% sucrose and 
0.2% gelrite. 96% rooting was achieved within 22days by culturing the in vitro formed shoots on 
half strength MS medium with 11.42μM IAA, 9.8μM indole-3-butyric acid, 0.46μM Kn and 
198.25μM phloroglucinol. Following a simple hardening procedure involving sequential transfer 
of plants to a greenhouse, polyhouse, and shade net, the tissue-cultured plants were transferred to 
the field where the survival rate was 100%. To this date 500 plants have been produced. Inter 
simple sequence repeat analysis has confirmed genetic uniformity of the tissue-cultured plants.
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3.2. Eugenia jambolana 
1. Ravi Kasiappan and et al, Anti-Diabetic Activity of Eugenia jambolana Seed Kernels on 
Streptozotocin-Induced Diabetic Rats .The present study evaluated the hypoglycemic activity of 
different parts of Eugenia jambolana seeds such as whole seed, kernel, and seed coat on 
streptozotocin-induced diabetic rats. Administration of the ethanolic extract of kernel at a 
concentration of 100 mg/kg of body weight significantly decreased the levels of blood glucose, 
blood urea, and cholesterol, increased glucose tolerance and levels of total proteins and liver 
glycogen, and decreased the activities of glutamate oxaloacetate transaminase and glutamate 
pyruvate transaminase in experimental diabetic rats. Whole seed showed a moderate 
hypoglycemic effect, and seed coat did not show any hypoglycemic effect. The hypoglycemic 
efficacy was compared with that of glibenclamide, a standard hypoglycemic drug. 
2. M.T. Pepato and et al, Lack of antidiabetic effect of a Eugenia jambolana leaf decoction on rat 
streptozotocin diabetes Streptozotocin-diabetic rats were treated for 17 days with a decoction 
of Eugenia jambolana (Myrtaceae) leaves (15%, w/v) as a substitute for water. Body weight, 
food and fluid intake, urine volume, glycemia, urinary glucose and urea were evaluated every 5 
days. The animals were sacrificed by decapitation and blood samples collected for the 
determination of glycemia, serum cholesterol, HDL-cholesterol, triglycerides and angiotensin-
converting enzyme. The weight of adipose and muscle tissues was also determined. There were 
no statistically significant differences between treated and untreated rats for any of the 
biochemical or physiological parameters. We conclude that, at least in this experimental 
model, Eugenia jambolana leaf decoction has no antidiabetic activity.
3. Das S and et al, The hepatoprotective activity of the ethanolic extract of the pulp of Eugenia 
jambolana in albino rats.
4. Venkata Charepalli and et al, Eugenia jambolana (Java Plum) Fruit extract exhibits anti-
Cancer activity against early stage human HCT-116 Colon cancer cells and colon cancer stem 
cells.
5. Debjith Bowmik and et al, Jamun or Indian Black berry is considered as a traditional medicine 
that helps in controlling diabetes. Specifically, jamun has an action on the pancreas, the main 
organ responsible for causing diabetes. The fruit, the seeds and even the juice of the jamun all 
play an important role in the treatment of diabetes. The jamun seeds contain a type of glucose 
called Jamboline, which checks the conversion of starch into sugar in cases of increased 
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production of glucose, the main reason behind your high sugar levels. It has anti-cancer and anti-
viral properties. Jamun juice has carminative and mild astringent properties. The extracts of the 
bark, seeds and leaves are used for the treatment of diabetes. The leaves have antibacterial 
properties and used for strengthening teeth and gums. Oral administration of dried alcoholic 
extracts of the seeds to diabetic patients was found to reduce the level of blood sugar and 
glycosuria in trials conducted at CDRI, Lucknow, India. The bark of black berry tree is 
astringent, digestive, diuretic, anthelmintic and is considered useful for throat problems. A 
decoction of the bark and powdered seeds is believed to be very useful in the treatment of 
diarrhea, dysentery and dyspepsia. The antibiotic activity of black berry extract has been widely 
studied and found useful against a number of microbial agents. The fruit is also considered to be 
stomachic, carminative, antiscorbutic and diuretic. Vinegar made from black berry fruit is 
administered in cases of enlargement of spleen, chronic diarrhoea and urine retention for 
ringworm treatment, water diluted juice is used as lotion.
6. Sadaf Rasheed and et al, Histological effect of Eugenia jambolana seed extract on liver of 
Adult albino rats.The therapeutic value of Eugenia jambolana, commonly known as   Jamun   in 
Hindi, has been recognized in different system of traditional medicine for the treatment of various 
conditions. Its seeds are used for the treatment of diabetes mellitus and hyperlipedemia by 
reducing the lipid levels in the body; this action is presumed to be due to blocking the action of 
enzyme 3-hydroxyl methyl glutaryl (HMG-CoA reductase in the liver. Herbal drugs are getting 
into use with the notion that these are relatively harmless; the practice has shown that many of 
them also have toxic effects. Since hardly any work is available on the toxic aspect of Eugenia 
Jamblana, the present study was planed to see the effect of ethanolic extract of Eugenia Jamblana 
on liver using albino rats as an experimental model.
7. Suman Bala Sharma and et al, Ameliorative effect of active principle isolated from seeds of 
Eugenia jambolana on carbohydrate metabolism in experimental diabetes. The aim of this study 
was to evaluate the antidiabetic activity of LH II purified from ethanolic seed extract of Eugenia 
jambolana in alloxan-induced mild diabetic (MD) and severely diabetic (SD) rabbits. Ethanolic 
extract upon chromatographic purification yielded partially purified hypoglycemic principle 
(SIII) which on further purification by sephadex LH 20 yielded pharmacological active 
compound LH II. Homogeneity of LH II was tested by HPLC. Phytochemical investigation of 
LH II by various structural spectra showed the presence of saturated fatty acid, Δ5 lipid and 
presence of sterol. LH II was administered orally at a dose of 10 mg kg−1 body weight to MD 
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and SD. LH II resulted, significant fall in FBG at 90 min (21.2% MD: 28.6% SD), 7th day 
(35.6% MD) and 15th day (59.6% SD). Glycosylated hemoglobin was significantly decreased 
(50.5%) in SD after 15 days treatment (Tt). Plasma insulin levels were significantly increased (P 
< .001). In vitro studies with pancreatic islets showed 3-fold increase in insulin levels as 
compared to untreated animals. LH II also showed extrapancreatic effect by significantly 
increasing (P < .001) the activity of key enzymes of glycolysis and significantly decreasing (P < 
.001) the activity of key enzymes of gluconeogenesis. Liver and muscle glycogen content were 
increased by 36.6 and 30% for MD, and 52 and 47% for SD, respectively. Thus, the present study 
demonstrates that LH II possesses potent antidiabetic activity and it is effective in both MD and 
SD rabbits.
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3.3.  PRECLINICAL IN VIVO ANIMAL MODELS OF DIABETES MELLITUS 
FOR SCREENING OF POTENTIAL ANTI-DIABETIC ACTIVITY
1. Pharmacological induction of Diabetes Mellitus by using Streptozotocin in rats:
Generally in the laboratories to create diabetogenic effect they will administered 
streptozotocin (STZ) with regard to their health condition and mortality rates. Normally Eight-
week-old rats, weighing from 200 to 230 g, were randomised into five groups of eight animals. 
Streptozotocin was administered by i.v. injection in doses of 40, 50, 60 and 70 mg/kg body 
weight. The animals were kept on a standard diet with free access to water for 4 months. The 
highest STZ dose (70 mg/kg) was lethal to the animals, the doses of 50 and 60 mg/kg induced 
persistent hyperglycaemia with glucose levels above 20 mM. Body weights of STZ treated rats 
from all experimental groups were significantly lower than those of control animals. 
Considerable polyuria was observed in all STZ treated rats. About 40 % of the STZ treated 
animals were found to develop overt cataract between days 90 and 100. At the end of the 
experiment, significant albuminuria was observed in the experimental groups administered 50 
and 60 mg/kg STZ doses. We conclude that young male rats, Breeding Facility, treated by a 
single i.v. STZ dose of 50 or 60 mg/kg developed a persistent disease state characterised by 
severe hyperglycaemia with major clinical signs of diabetes mellitus.
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4. AIM AND OBJECTIVES
The present investigation was aimed to screen the anti diabetic and hypolipidemic activity 
of Crateva magna root and Eugenia jambolana seed and its combination on diabetic rats.
Objective
The objective of the present study was to,
a. Find out the phytochemical constituents present in the hydroalcoholic extract of the root
of Crateva magna plant.
b. Find out LD50 dose of the hydroalcoholic extract of root of Crateva magna plant.
c. Evaluate the anti diabetic, hypolipidemic activity of Crateva magna plant. 
d. Evaluate the anti diabetic, hypolipidemic activity of Eugenia jambolana plant.
e. And evaluate the anti diabetic activity of 1:1 combination of Crateva magna root and 
Eugenia jambolana seed.
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5. PLAN OF WORK
1. Collection of the plants (Crateva magna root and Eugenia jambolana seed).
2. Authentification of the plant, shade drying granulation of the root and seed of the plant.
3. Extraction with solvents.
4. Preliminary Phytochemical screening of HAECMR.
5. Carrying out acute toxicity to determine LD50 VALUE.
6. Carrying out oral glucose tolerance test.
7. Carrying out the anti-diabetic activity for Crateva magna root Eugenia jambolana seed.
8. Carrying out hypolipidemic activity for Crateva magna root Eugenia jambolana seed.
9. Estimation of biochemical parameters for Crateva magna root.
10. Determination of atherogenecity.
11. Estimation of body weight.
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6. MATERIALS AND METHODS
6.1. PLANT MATERIAL
Root of Crateva magna and Eugenia jambolana seed was collected from Nallamalla 
forest, Mahaboob nagar district, Andhra Pradesh, India during the month of May. It was 
authenticated from Osmania University, Hyderabad.
Extraction of plant material
The root was shade dried and powdered coarsely. The coarse powder obtained was 
extracted exhaustively with 70% ethanol in soxhlet apparatus and filtered. The extract was 
concentrated under temperature and pressure to get dry residue and stored in a desicators. The 
same method has applied to seeds also.
6.2. Phytochemical screening of hydroalcoholic root extract
Preliminary Phytochemical analysis was carried to find out the Phytoconstituents present 
in crude extract. Crateva magna showed the presence of glycosides, tannins, saponins, terpenoids 
and flavonoids.
Test solution: The hydroalcoholic extract of Crateva magna was taken and dissolved in water.
6.3.a.ALKALOIDS
i) Dragendorff  s test
To the extract, Dragendorff  s reagent (potassium bismuth iodine solution) was added, 
reddish brown precipitate was produced.
ii) Mayer  s test
To the extract, Mayer  s reagent (potassium mercuric iodine solution) was added, cream 
colour precipitate was produced.
iii) Wagner  s test
To the extract, Wagner  s reagent (iodine-potassium iodide solution) was added, reddish 
brown precipitate was produced.
iv) Hagner  s test
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To the extract, Hagner  s reagent (saturated solution of picric acid) was added, yellow 
precipitate was produced.
v) Tanic acid test
To the extract, tannic acid solution was added, buff colour precipitate was produced.
3.3.b. AMINOACIDS
i) Millon  s test
To the test solution, about 2ml of Millon  s reagent was added, a white precipitate was 
obtained indicating the presence of amino acid.
ii) Ninhydrin test
To the test solution, Ninhydrin solution was added, boiled, violet colour was produced 
indicating the presence of amino acid.
6.3.c. PROTEINS
i) Warming test
The test solution was heated in a boiling water bath, proteins got coagulated.
ii) Test with trichloroacetic acid
To the test solution trichloroacetic acid was added, precipitate was formed.
iii) Hydrolysis test
The test solution was hydrolysed with hydrochloric acid or sulphuric acid, Ninhydrin test 
was carried out for amino acids.
iv) Biuret test
To the test solution (2 ml), Biuret reagent (2 ml) was added, violet colour was produced 
indicating the presence of proteins.
v) Xanthoprotein test
To the (5 ml) of test solution, 1 ml of concentrated nitric acid was added and boiled, 
yellow precipitate was formed. After cooling it, 40% sodium hydroxide solution was added an 
orange colour was formed.
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6.3.d. CARBOHYDRATES
i) Molish test
To the test solution, few drops of alcoholic α-napthol was added, then few drops of 
concentrated sulphuric acid was added through the sides of test tube, purple to violet colour ring 
appeared at the junction.
ii) Barfoed  s test
1 ml of the test solution, was heated with 1 ml of Barfoed  s reagent on water bath, if red 
cupric oxide was formed, monosaccharide was present.
iii) Selivanoff  s test (Test of Ketones)
To the test solution, crystals of resorcinol and equal volume of concentrated hydrochloric 
acid were added and heated on a water bath, rose colour was produced.
iv) Test for pentoses
To the test solution, equal volume of hydrochloric small amount of phloroglucinol was 
added and heated, red colour was produced.
v) Fehling  s test
To the test solution, equal quantity of Fehling  s A and B were added and heated on water 
bath, brick red precipitate was formed.
vi) Benedict  s test
To the test solution, 5ml of Benedict  s reagent was added and heated on water bath, red 
precipitate was formed.
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6.3.e. FLAVONOIDS
i) Shinoda test
To the test solution, few magnesium turnings were added and concentrated hydrochloric 
acid was added drop wise, pink scarlet, crimson red or occasionally green to blue colour appeared 
after few minutes.
ii) Alkaline reagent test
To the test solution, few drops of sodium hydroxide solution was added, intense yellow 
colour was formed which turned to colourless on addition of few drops of dilute acid indicating 
the presence of flavonoids.
iii) Zinc hydrochloride test
To the test solution, a mixture of zinc dust and concentrated hydrochloric acid were 
added. It gave red colour after few minutes.
6.3.f. Glycosides
i) General test
Test A
200 mg of drug was extracted with 5 ml of dilute sulphuric acid by warming on 
waterbath. It was filtered then the acid extract was neutralized with 5% solution of sodium 
hydroxide. 0.1 ml of Fehling  s solution A and B was added until it became alkaline (tested with 
pH paper) and heated on water bath for 2 minutes. The quantity of red precipitate formed was 
noted and compared with that of formed in Test B.
Test B
200 mg of drug was extracted using 5 ml of water instead of dilute sulphuric acid. After 
boiling add equal amount of water and 0.1 ml of Fehling  s solution A and B was added until it 
became alkaline (tested with pH paper) and heated on water bath for 2 minutes. The quantity of 
red precipitate formed was noted the quantity of precipitate formed in Test B was compared with 
that of formed in Test A.
The precipitate in Test A was greater than in Test B, showing the presence of glycoside.
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6.3.g. Tannins (Phenolic compounds)
i) Ferric chloride test
To the test solution, ferric chloride solution was added, green colour appeared showing 
the presence of condensed tannins.
ii) Phenazone test
To the test solution, 0.5 grams of sodium acid phosphate was added, warmed and filtered. 
To the filtrate add 2% phenazone solution, bulky precipitate was formed which was often 
coloured.
iii) Gelatin test
To the test solution, 1% gelatine solution containing 10% sodium chloride was added. 
Precipitate was formed.
iv) Test for catechin
Matchstick was dipped in the test solution, dried it and lastly moistened with concentrated 
hydrochloric acid. Then the stick was warmed near to flame. The colour of the wood changed to 
pink due to phloroglucinol (Phloroglucinol was fomed when catechins were treated with acids).
6.3.h. STEROIDS AND TERPENOIDS
i) Libermann-Burchard test
The extract was treated with few drops of acetic anhydride, boiled and cooled. 
Concentrated sulphuric acid was added from the side of the test tube, brown ring was formed at 
the junction of two layers and upper layer turned green which showed the presence of steroids 
and formation of deep red colour indicating the presence of triterpenoids.
ii) Salkowski test
The extract was treated with few drops of concentrated sulphuric acid, red colour at lower 
layer indicates the presence of steroids and formation of yellow coloured lower layer indicating 
the presence of triterpenoids.
The same method of extraction has been done for seeds of Eugenia jambolana.
Comparetive study of Antidiabetic and hypolipidemic activity of Crateva magna root & Eugenia jambolana seed and 
its combination in rats . 
Department	of	Pharmacology,	Cherraan  s	College	of	Pharmacy,	Coimbatore Page	32
6.4 ACUTE TOXICITY STUDY
1. Crateva magna
Whenever an investigator administers a chemical substance to a biological system, 
different types of interactions can occur and a series of dose-related responses result. In most 
cases these responses are desired and useful, but there are a number of other effects which are not 
advantageous. These may or may not harmful to the patients. The types of toxicity tests which are 
routinely performed by pharmaceutical manufacturers in the investigation of a new drug involve 
acute, sub-acute and chronic toxicity. Acute toxicity is involved in estimation of LD50 (the dose 
which has proved be lethal to 50% of the tested group of animals.)
Determination of oral toxicity is usually an initial screening step in the assessment and the 
evaluation of the toxic characteristics of all compounds. This article reviews the methods so far 
utilized for the determination of median lethal dose (LD50) and the new different categories of 
substances before its final acceptance by regulatory bodies.
Organisation of economic co-operation and development (OECD) regulates guidelines for 
acute oral toxicity. It is an international organization which works with the aim of reducing both 
the number of animals and the level of pain associated with acute toxicity testing. To determine 
the acute toxicity OECD frames the following guideline methods.
OECD 401 - Acute oral toxicity
OECD 420 - Acute oral toxicity : fixed dose procedure
OECD 423 - Acute oral toxicity : Acute toxic classic method
OECD 425 - Acute oral toxicity : Up and down procedure (UDP)
In the present study, the acute oral study of Actinomers dichotoma Bedd. was carried out
according to OECD 423 guideline (Acute oral toxicity : Toxic classic method).
Acute oral toxicity:
Acute oral toxicity refers to those adverse effects occurring following oral administration 
of a single dose of a substance or multiple doses given within 24 hrs.
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LD50 (median lethal dose):
LD50 statistically derived single dose of a substance that can be expected to cause death in 
50 percent of animals when administered by the oral route. The LD50 value is expressed in terms 
of weight of test substance per unit weight of test animal (mg/kg).
Principle
It is the principle of the test that, based on a stepwise procedure with the use of a 
minimum number of animals per step, sufficient information is obtained on the acute study of the 
test substance to enable its classification. The substance is administered orally to a group of 
experimental animals at one of the defined doses. The substance is tested using a stepwise 
procedure, each step using three animals of a single sex (normally females). Absence or presence 
of compound-related mortality of the animals dosed at one step will determine the next step, i.e.,
∑ No further testing is needed.
∑ Dosing of three additional animals, with the same dose.
∑ Dosing of three additional animals at the next higher or the next lower dose level.
Selection of animal species
The preferred rodent species was the rat. Normally females were used. Females were 
generally slightly more sensitive. Healthy young adult animals of commonly used laboratory 
strains should be employed. Females should be nulliparous and non-pregnant. Each animal, at the 
commencement of its dosing should be between 8 to 12 weeks old.
Administration of doses
The test substance was administered in a single dose by gavage using an oral feeding 
needle. Animals should be fasted to dosing (e.g. with the rat food but not water should be 
withheld over-weight with the mouse food but not water should within for 3-4 hrs). Following the 
period of fasting, the animals should be weighed and the test substance administered. After the 
substance has been administered, food may be with held for a further 3-4 hrs in rats.
Animals were observed individually after dosing at least once during the first 30 minutes, 
periodically during the first 24 hours with the special attention given during the first 4 hrs and 
daily thereafter, for a total of 14 days except where they need to be removed from the study and 
humanely killed for animal welfare reasons or found dead. However, the duration of observation 
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should not be fixed rigidity. It should be determined by the toxic reactions time of onset and 
length of recovery period and may thus be extended when considered necessary. The times at 
which signs of toxicity appear and disappear are important especially if there is a tendency for 
toxic signs to be delayed. All observations are systematically recorded with individual records 
being maintained for each animal.
Dose selection
According to OECD 423 guideline dose was selected on the basis of maximum tolerable 
dose (NOAEL), as there was no lethal dose observed upto 3000mg/kg. Thus dose was selected as 
1/10th of 3000mg/kg, i.e., 300mg/kg was taken as high dose and 100mg/kg was taken as low 
dose.
Same procedure was adopted for Eugenia jambolana and findings given in the results.
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6.5. Evaluation of Anti diabetic, Hypolipidemic activity 
6.5.1. Animals and treatment schedule:
Thirty male rats, 6 weeks old and weighing roughly above 150g, were procured from 
Nishka Labs and were housed in polupropylene cages in a temperature controlled room (25±2˚C) 
witha 12h light/12h dark cycle. All rats were adapted and fed a standard pellet diet for 1 week. 
Rats had unrestricted access to food and water. Food intakes were monitored daily, and body 
weights measured weekly. All rats were randomly divided into five groups (n=6),
Group I:- Normal control group.
Group II:- Diabetic control group fed with STZ.
Group III:- STZ treated group with standard drug Glibenclamide (10mg/kg;p.o).
Group IV:- STZ treated group with Crateva magna root extract 100mg/kg;p.o.
Group V:- STZ treated group with Crateva magna root extract 300mg/kg;p.o.
All the above groups were treated for 21 days and rats were maintained in accordance with the 
National Institute of nutrition, Indian Council of Medical Research, Hyderabad, India guidelines 
for the care and use of laboratory animals.
The same procedure was followed for Eugenia jambolana seed and 1:1 combination of Carteva 
magna root and Eugenia jambolana seed.
6.5.2. Blood collection techniques used in the present study
Blood and tissue collection:
At the end of the study, blood samples were collected in the heparinized tube by 
puncturing the orbital venous plexus of 12h fasted and anaesthetized (slight exposure to ether) 
rats. Whole blood samples were centrifuged at 4500 rpm for 10 min at 4˚C and plasma was 
separated out and stored at -70˚C until further analysis. All the animals were sacrificed by 
cervical dislocation, liver, pancreas were removed and rinsed with chilled phosphate buffered 
saline (pH 7.0) and weighed.
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Picture no: 5. Retro-orbital bleeding technique
6.5.3. ESTIMATION OF BIOCHEMICAL PARAMETERS
The biochemical parameters was estimated by using commercially available kits, according to the 
manufacturer protocol, the following parameters GLUCOSE(by accu-check active) total 
cholesterol, triglycerides, HDL, LDL, VLDL were estimated by using auto in NISHKA LABS.
6.5.3.a. Estimation of glucose
The glucose levels are estimated by collecting the blood samples. Small amount of blood was 
obtained from tail vein of rat. By placing a drop of blood on glucometer strip there by the strip 
was inserted into the glucometer where it displaces the glucose level in the drop of blood in 
mg/dl.
6.5.3.b. Estimation of total cholesterol
Method   Cholesterol oxidase-peroxidase
Principle
Cholesterol esterase hydrolyses cholesterol esters into free cholesterol and fatty acids. In 
the second reaction, cholesterol oxidase converts cholesterol to cholest-4-en-3-one and hydrogen 
peroxide. In presence of peroxidise, hydrogen peroxidise oxidatively couples with 4-
aminoantipyrine and phenol to produce red quinoneimine dye which has absorbance maximum at 
510 nm. The intensity of the red colour is proportional to the amount of total cholesterol in the 
specimen.
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Cholesterol esters ????????????????????⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯? cholesterol + fatty acids.
Cholesterol + O? ???????????????????⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯? H?O? + cholest-4-en-3-one.
2H?O? + 4-aminoantipyrine???????????⎯⎯⎯⎯⎯⎯? red quinoneimine dye + H?O? + phenol.
Reagent composition
S.NO REAGENT CONCENTRATION
1 Buffer, pH 6.8 50mMol/lit
2 Cholesterol oxidase ≥100IU/L
3 Cholesterol esterase ≥150IU/L
4 Peroxidase ≥500IU/L
5 4-amino antipyrine 0.5mMol/lit
6 Phenol ≥10mMol/lit
7 Stabilizer/surfactant Qs
Assay parameters
Reaction type - end point Linearity - 1000 mg/dl
Reagent volume - 1 ml (1000 µl) Zero setting with - reagent blank
Wavelength - 510 nm Sample volume - 0.01 ml (10 µl)
Blank absorbance limit - 0.300 Abs Standard concentration - 200 mg/dl
Reaction time - 5 minutes at 37˚C/10 minutes at room temperature (25˚-30˚C)
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Procedure
Sample - serum
The required amount of reagent before use was pre warmed at room temperature, the assay was 
performed as given below.
Serum Standard Blank
10 µL 10 µL -
Reagent 1000 µL 1000 µL 1000 µL
Incubation
The assay mixture was incubated for 5 minutes at 37˚C for 10 minutes at room 
temperature (25˚-30˚C). After incubation the absorbance of the assay mixture was measured 
against blank at 510 nm. The final colour was stable for two hours if not exposed to direct light.
Calculation
Total cholesterol (mg/dL) = (absorbance of test/absorbance of standard) ¥ 200
Estimation of triglycerides
6.5.3.c. Triglycerides
Method   Glycerol 3-phosphate oxidase- GPO-PAP METHOD
Principle
Triglycerides are hydrolysed by lipoprotein lipase (LPL) to produce Glycerol and free 
fatty acid (FFA). In presence of glycerol kinase (GK), adenosine tri phosphate (ATP) 
phosphorylates glycerol to produce glycerol 3- phosphate and adenosine diphosphate (ADP). 
Glycerol 3- phosphate is further oxidized by glycerol 3-phophate oxidase (GPO) to produce 
dihydroxyacetone phosphate (DAP) and H2O2. In thepresence of peroxidise (POD), hydrogen 
peroxide couples with 4-aminoantipyrine (4-AAP) and 4-chlorophenol to produce red 
quinoneimine dye. Absorbance of the coloured dye is measured at 505 nm and is proportional to 
triglycerides concentration in the sample.
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Triglyceride ??????????? ???????⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯? glycerol + free fatty acids
Glycerol + ATP ???????????????⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯? Glycerol 3-phosphate + ADP
Glycerol 3-phosphate 
???????????????????????????⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯⎯? dihydroxyacetone phosphate + H?O?
2H?O? + 4-aminoantipyrine + 4-chlorophenol???????????⎯⎯⎯⎯⎯⎯? quinoneimine dye + 4H?O?
Reagent composition
Reagent No. Reagent Composition Concentration
1 Triglyceride mono 
reagent
Pipers buffer, (PH 7)
Mg ions
p-Chlorophenol
ATP
Potassium 
ferrocyanide
Amino-4-antipyrine
Lipoprotein lipase
Glycerol kinase
Glycerol-3-phosphate 
oxidase
Peroxidase
Detergents, 
preservatives, 
stabilizers
50 mmol/L
14.8 mmol/L
2.7 mmol/L
3.15 mmol/L
10 mmol/L
0.31 mmol/L
≥2000 U/L
≥500 U/L
≥4000 U/L
≥500 U/L
Qs
2 Triglyceride standard Glycerol 
(Triglycerides 
equivalent)
Preservatives, 
stabilizers
200 mg/Dl
Qs
Assay parameters
Mode - end point Wavelength - 505 nm
Flow-cell - 37˚C Optical path length - 1 cm
Blanking - reagent blank Reagent volume - 1000 µL
Sample volume - 10 µL Incubation time - 10 minutes at 37˚C
Concentration of std - 200 mg/dL Stability of colour - 1 hour
Linearity - 1000 mg/dL Permisible - <0.3 AU
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Procedure
Sample - serum
Samples Pipette into tube marked Blank Standard Test
Serum - - 10 µL
Reagent 2 - 10 µL -
Reagent 1 1000 µL 1000 µL 1000 µL
The serum was mixed well. Incubated at 37˚C for 10 minutes.
The analyser was programmed as per assay parameters.
1. The analyser was blanked with reagent blank.
2. The absorbance of standard followed by the test was measured.
3. The results were calculated as per given formula.
Serum triglycerides (mg/dL) = (absorbance of test/absorbance of standard) ¥ 200
6.5.3.d. HDL
Method-Polyethylene Glycol-CHOD-PAP with LCF (lipid clearing factor)
Principle
Low and very low density lipoproteins (VLDL) are precipitated by a solution containing 
PEG 6000, leaving behind the high density lipoproteins in the solution, HDL cholesterol is 
estimated in the supernatant by a series of enzymatic reactions which are initiated by the 
oxidation of cholesterol to cholestenone by cholesterol oxidase, accompanied by the formation of 
hydrogen peroxide. In a second reaction catalysed by peroxidase, 4-aminoantipyrine and phenol 
react with hydrogen peroxide to form red colour quinoneimine. Asorbance at 505 nm is directly 
proportional to HDL cholesterol concentration in the specimen.
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Reagent compositions
Precipitating reagent(Reagent 3);PEG 6000; Stabilizer; Preservative; HDL-cholesterol 
standard 50 mg/dL (Reagent 4). Cholesterol; Stabilizer; Preservative.
Assay parameters
Mode - end point Wavelength - 505 nm
Flow-cell - 37˚C Optical path length - 1 cm
Blanking - reagent blank Reagent volume - 1000 µL
Sample volume - 100 µL Stability of colour - 1 hour
Concentration of standard - 50 mg/dL Maximum absorance limit - 2.0
Incubation time - 10 minutes at 37˚C/30 minutes at room temperature (15-30˚C)
Procedure
Sample-serum
Step A: HDL cholesterol separation
Samples pipette into centrifuge tube Quantity
Sample 200 µL
Precipitating reagent 200 µL
The serum was mixed well, kept at room temperature (15-30˚C) for 10 minutes and then 
centrifuged at 2000 rpm for 15 minutes to obtain a clear supernatant.
Comparetive study of Antidiabetic and hypolipidemic activity of Crateva magna root & Eugenia jambolana seed and 
its combination in rats . 
Department	of	Pharmacology,	Cherraan  s	College	of	Pharmacy,	Coimbatore Page	42
Step B: Colour development.
Samples pipette into tube marked Blank Standard Test
Supernatant from step A - 100 µL
HDL cholesterol standard - 100 µL -
Cholesterol reagent 1000 µL 1000 µL 1000 µL
Mixed well, incubated at 37˚C for 10 minutes or at room temperature (15-30˚C) for 30 minutes. 
The absorbance was read against blank at 505 nm within 60 minutes.
Calculation:
HDL cholesterol (mg/dL) = (absorbance of test/absorbance of standard) ¥ 50 ¥ 2
6.5.3.e. VLDL
The VLDL was calculated by using the following formula
VLDL (mg/dl) = (Triglyceride/5)
6.5.3.f. LDL
The LDL was calculated by using the following formula
LDL (mg/dl) = Total cholesterol - (HDL + VLDL)
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ORAL GLUCOSE TOLERANCE TEST
A singular feature of Diabetes mellitus is impaired glucose tolerance. This is unmasked 
by an oral glucose tolerance test, in which blood glucose levels are sampled after overnight and 
then minutes to hours after an oral dose of glucose. In normal persons blood glucose levels rise 
only modestly, and a brisk insulin pancreatic insulin response ensures a return to normoglycemic 
levels within an hour. In diabetic individuals and those in preclinical stage, blood glucose rises to 
abnormally high levels for a sustained period. This may result from an absolutely lack of 
pancreatic insulin release or from impaired target tissue response to insulin or both.
Procedure:
OGTT is carried out in the diabetic induced rats. The rats were divided into 5 groups 
consisting of 6 animals in each group.
Group I:- Norma control received 0.9% saline.
Group II:- Diabetic control received 0.9% saline.
Group III:- Diabetic rats treated with 10mg/kg of std glibenclamide
Group IV:- received HAECMR (100mg/kg;p.o) + glucose (2gm/kg;p.o)
Group V:- received HAECMR (300mg/kg;p.o) + glucose (2gm/kg;p.o)
After 60 min of drug administration, the rats of normal and diabetic groups were orally 
treated with glucose (2gm/kg;p.o). The blood samples were drawn from the tail vein at 0, 30, 60, 
90 and 120 min after glucose feeding. Glucose levels were determined using an Accu-Check 
Advantage Blood Glucose Monitor (Roche Group, Indianapolis, IN, USA).
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EXPERIMENTAL DESIGN
Five groups of rats, six in each group received the following treatment schedule for 21
days.
GROUP I:- normal control.
GROUP II:- STZ treated control.
GROUP III:- STZ + Glibenclamide (10mg/kg;p.o).
GROUP IV:- STZ + HAECMR (100mg/kg;p.o).
GROUP V:- STZ + HAECMR (300mg/kg;p.o).
Root extract of Crateva magna, standard drug were administered with the help of oral 
feeding needle.
STZ- Streptozotocin.
HAECMR- Hydroalcoholic extract of Crateva magna root.
Fasting blood samples were drawn from retro orbital venous plexus of rats at 4 intervals (each 
interval = 7 days) for 21 days till the end of the study 0, 7, 14, 21 days.
ESTIMATION OF BIOCHEMICAL PARAMETERS
On 0, 7, 14, 21 days fasting blood samples were collected, serum was separated and 
analysed for glucose, 1, 12, 24,36 and 48th days total cholesterol, triglycerides, HDL, VLDL, 
LDL and plasma insulin levels.
EVALUATION OF WEIGHT OF BODY
Body weights of all the animals in each group was measured during the study period initially 
before the start of the study and finally at the end of the study. 
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STATISTICAL ANALYSIS
Statistical analysis was done by using GRAPHPAD PRISM 5.0.
All the values of OGTT, biochemical parameters, and body weight were expressed as 
Mean ± Standard Error Mean (S.E.M.). The values were analyzed for statistically significance 
using one-way analysis of variance (ANOVA), followed by Dunnett  s tests.
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7. RESULTS AND DISCUSSION
7.1 RESULTS
7.1.1. Appearance and percentage yield of HAECMR
The colour consistency of HAECMR was noted and the percentage yield was calculated 
and reported.
Colour - brownish
Consistency    - semisolid
Percentage yield  - 10.12%
7.1.1.a. Preliminary phytochemical screening:
Table no: 4. Results of the preliminary phytochemical constituents present in HAECMR
S.NO Plant constituents HAECMR
1 Alkaloids +ve
2 Aminoacids +ve
3 Proteins +ve
4 Carbohydrates +ve
5 Flavonoids +ve
6 Glycosides +ve
7 Tanins +ve
8 Terpenoids +ve
9 Saponins +ve
10 Phenolic +ve
+ve indicates present and -ve indicates absent
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RESULTS:
The phytochemicals present in the hydroalcoholic extract of Crateva magna were 
aminoacids, carbohydrates, flavonoids, glycosides, Tanins, terpenoids, saponins, phenolic 
compounds.
7.1.2.ACUTE TOXICITY STUDY
OCED 423- Acute oral toxicity : Toxic classic method
The effect of different doses of hydro alcoholic extract of Crateva magna root on acute 
toxicity test.
Table no: 5. Results of the percentage mortality, signs of toxicity of different doses of 
HAECMR treated groups
Group (n=3) Treatment Mortality 
at 14th day
% 
Mortality
Signs of toxicity
1 Normal control 0/3 0 -
2 HAECMR 300 mg/kg; p.o., 0/3 0 -
3 HAECMR 2000 mg/kg; 
p.o.,
0/3 0 -
4 HAECMR 3000 mg/kg; 
p.o.,
0/3 0 -
+ indicates presence and - ve indicates absence
RESULTS
The percentage mortality signs of different doses of HAECMR treated groups was shown 
in the table.
The different doses of hydroalcoholic extract of Crateva magna root treated rats showed 
0% mortality and absence of toxicity. This revealed the non-toxic nature of the hydroalcoholic 
extract of  Crateva magna root even at high dose of 3000mg/kg body weight.
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7.1.3. ORAL GLUCOSE TOLERANCE TEST (OGTT)
The effect of different doses of Hydroalcoholic extract of Crateva magna root on oral 
glucose tolerance test in normal rats.
Table no: 6. Results of effects of HAECMR on OGTT
Treatment SERUM GLUCOSE (mg/ml)
0 min 30 min 60 min 90 min 120 min
1 Normal control 80.56± 1.68
152.20± 1.25 130.70± 1.12 120.1± 1.62 112.37± 2.21
2 STZ treated diabetic control
203.71± 2.52 330.21± 2.51 321.43± 2.77 310.44± 3.63* 298.51± 3.14
3 Glibenclamide(10mg/kg;p.o) 
+ glucose (2 gm/kg;p.o)
275.43± 7.64 350.63± 7.31 387.50± 7.37 320.71± 6.46 250.31± 8.34
4 HAECMR (100 mg/kg;p.o) + 
glucose (2 gm/kg;p.o)
298.86± 12.31 383.56± 5.08 390.5± 7.13** 311.40± 6.92 265.73± 5.96**
5 HAECMR (300 mg/kg;p.o) + 
glucose (2 gm/kg;p.o)
298.88± 13.52 369.57± 8.10 388.51± 7.24 320.71± 6.20** 253.31± 9.82**
The values were estimated as Mean+S.E.M (n=6). Extract treated, Glibenclamide treated and 
glucose treated were compared with the vehicle control and STZ treated. **P<0.01-Statistically 
very significant; *P<0.05-Statistically significant; ns - Statistically not significant.
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Graph no: 1. Diagramatic representation of results of the effects of HAECMR on OGTT
GBN-Glibenclamide(10mg/kg;p.o), GLU-Glucose(2gm/kg;p.o), HD-High dose(300mg/kg;p.o) of 
extract, LD-low dose(100mg/kg;p.o), STZ-Streptozotocin
Results
In Glucose Tolerance Test, the Glucose levels were estimated at 0,30,60,90 and 120 Mins
respectively. The blood sugar level of extract treated groups were found compared to be diabetic 
control and the effects were dose dependant. Group II & IV glucose lowering efficiency between 
90-120 Mins & were comparable to diabetic standard shown in table.
The experiment showed that OGTT measures the ability to use glucose, the bodys main 
source of energy, used to diagnose pre & post diabetes, glucose lowering effects were found after 
oral administration of extracts in rats may be due to the presence of hypoglycaemic flavanoids, 
terpenes or saponins that also requiring further investigation.
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7.1.4. ESTIMATION OF BIOCHEMICAL PARAMETERS
7.1.4.a. Estimation of blood glucose
Table no: 7. Results of the effects of HAECMR on serum glucose levels
The values were expressed as Mean ± S.E.M. (n=6) by using ANOVA followed by Dunnet test. 
STZ treated control (Diabetic control) was compared with vehicle control extract treated and 
Glibenclamide treated. *** P<0.001-Statistically highly significant; **P<0.01-Statistically very 
significant; *P<0.05-Statistically significant; ns - Statistically not significant
Treatment Serum glucose levels (mg/dl)
0st day 7th day 14th day 21st day
1 Normal control 85.81± 5.52 87.21±5.36 79.59±5.64 83.45±5.72
2 STZ treated diabetic 
control
195.47± 6.33*** 216.25±8.36*** 232.21±10.299*** 256.40±8.65***
3 Glibenclamide(10 
mg/kg;p.o) + STZ
294.71± 12.04 239.45±5.71** 206.21±7.74** 181.21±7.22**
4 HAECMR (100 
mg/kg;p.o) + STZ
298.01±12.31** 258.63±7.33*** 230.52±11.30** 198.20±9.63**
5 HAECMR  (300 
mg/kg;p.o) + STZ
298.88± 13.52 235.11±5.54*** 210.03±3.35** 185.71±7.84***
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Graph no: 2. Diagramatic representation of results of the effects of the HAECMR on Serum 
glucose levels
STZ- Streptozotocin control,
GBN- Glibenclamide(10mg/kg;p.o)
LD-low dose(100mg/kg;p.o) of extract
HD-high dose(300mg/kg;p.o) of extract.
RESULTS
The blood glucose levels were measured on 0, 7th, 14th, 21st days were showed in Table 
no. 7. When compared with normal control, STZ treated diabetic control group on 0, 7th, 14th and
21st days showed significant (p<0.001) values as compared to STZ treated diabetic control group. 
Glibenclamide(10mg/kg;p.o)+STZ treated diabetic group showed significant decrease in blood 
glucose levels on 7th, 14th, 21st day(p<0.05). When compared to STZ treated diabetic control 
group HAECMR (300mg/kg;p.o) showed significant decrease in blood glucose levels(p<0.05)
and its effect is almost comparable to that of Glibenclamide. 
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7.1.4.b ESTIMATION OF TOTAL CHOLESTEROL
Table no: 8. Results of the effects of HAECMR on serum total cholesterol levels
Group Treatment Serum total cholesterol (mg/dl)
1st day 48th day
1 Normal control 71.28±5.23 72.18±7.09
2 STZ treated control 73.63±7.35 118.30±16.19
3 Glibenclamide (10 mg/kg;p.o) + 
STZ
68.15±3.12 93.93±10.2
4 HAECMR (100 mg/kg;p.o) + 
STZ
69.16±6.12 97.38±7.32
5 HAECMR (300 mg/kg;p.o) + 
STZ
67.79±4.14 76.7±4.78*
The values were expressed as Mean ± S.E.M. (n=6) by using ANOVA followed by Dunnet test. 
STZ treated control (Diabetic control) was compared with the vehicle control, extract treated and 
Glibenclamide treated. *** P<0.001-Statistically highly significant; **P<0.01-Statistically very 
significant; *P<0.05-Statistically significant; ns - Statistically not significant.
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Graph no: 3. Diagramatic representation of the results of the effects of the HAECMR on 
total cholesterol levels
STZ- Streptozotocin, GBN-Glibenclamide(10mg/kg;p.o),
LD-lower dose(100mg/kg;p.o) of extract, HD-higher dose(300mg/kg;p.o) of extract.
RESULTS
When compared with the STZ treated diabetic control group, Glibenclamide+STZ treated 
group showed significant decrease in total cholesterol levels(p<0.05). When compared with STZ
treated diabetic group control group and Glibenclamide+STZ treated group HAECMR 
(300mg/kg;p.o) group showed significant decrease in total cholesterol levels(p<0.05).
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7.1.4.c. ESTIMATION OF TRIGLYCERIDES
Table no: 9. Results of the effects of HAECMR on serum triglyceride levels
Group Treatment Serum triglycerides 
(mg/dl)
1st day 48th day
1 Normal control 54.27±3.71 59.20±4.33
2 STZ treated control 57.56±3.16 86.15±2.89
3 Glibenclamide(10mg/kg;p.o) + 
STZ
50.09±2.81 68.39±3.98
4 HAECMR (100 mg/kg;p.o) + STZ 55.12±7.1 73.29±8.0
5 HAECMR (300 mg/kg;p.o) + STZ 52.33±5.12 55.2±3.41*
The values were expressed as Mean ± S.E.M. (n=6) by using ANOVA followed by Dunnet test. 
STZ treated control (Diabetic control) was compared with vehicle control extract treated and 
Glibenclamide treated. *** P<0.001-Statistically highly significant; **P<0.01-Statistically very 
significant; *P<0.05-Statistically significant; ns - Statistically not significant
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Graph no: 4. Diagramatic representation of the results of the effects of the HAECMR on 
TG levels
STZ-Streptozotocin, GBN-Glibenclamide(10mg/kg;p.o),
LD-lower dose(100mg/kg;p.o) of extract, HD-higher dose(300mg/kg;p.o) of extract.
RESULTS
When compared with the STZ treated diabetic control group, Glibenclamide+STZ treated 
group showed significant decrease in Serum triglycerides level(p<0.05). When compared with 
STZ treated diabetic control group and Glibenclamide+STZ treated group HAECMR 
(300mg/kg;p.o) showed significant decrease in Serum triglycerides level(p<0.05).
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7.1.4.d. ESTIMATION OF HDL
Table no: 10. Results of the effects of HAECMR on serum HDL levels
Group Treatment Serum HDL (mg/dl)
1st day 48th day
1 Normal control 20.72±3.56 20.23±2.68
2 STZ treated control 18.49±4.16 31.01±3.51
3 Glibenclamide(10mg/kg;p.o) + 
STZ
20.14±3.69 31.35±2.76
4 HAECMR (100 mg/kg;p.o) + STZ 15.49±4.73 31.73±2.89
5 HAECMR (300 mg/kg;p.o) + STZ 17.57±3.84 35.06±3.16*
The values were expressed as Mean ± S.E.M. (n=6) by using ANOVA followed by Dunnet test. 
STZ treated control (Diabetic control) was compared with vehicle control, extract treated and 
Glibenclamide treated. *** P<0.001-Statistically highly significant; **P<0.01-Statistically very 
significant; *P<0.05-Statistically significant; ns - Statistically not significant
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Graph no: 5. Diagramatic representation of results of HAECMR on HDL
STZ-Steptozotocin, GBN-Glibenclamide(10mg/kg;p.o),
LD-lower dose(100mg/kg;p.o) of extract, HD-higher dose(300mg/kg;p.o) of extract.
RESULTS
When compared to STZ treated diabetic control group and Glibenclamide+STZ treated group, 
HAECMR (300mg/kg;p.o) showed significant increase in HDL levels(p<0.05).
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7.1.4.e. ESTIMATION OF LDL
Table no: 11. Results of the effects of HAECMR on serum LDL levels
Group Treatment Serum LDL (mg/dl)
1st day 48th day
1 Normal control 39.71±5.24 40.11±3.81
2 STZ treated control 43.63±4.68 70.06±12.0
3 Glibenclamide(10mg/kg;p.o) + 
STZ
38.00±5.11 48.91±8.30
4 HAECMR (100 mg/kg;p.o) + STZ 42.65±2.48 51.0±3.53
5 HAECMR (300 mg/kg;p.o) + STZ 39.76±2.64 40.6±0.04*
The values were expressed as Mean ± S.E.M. (n=6) by using ANOVA followed by Dunnet test. 
STZ treated control (Diabetic control) was compared with the vehicle control, extract treated and 
Glibenclamide treated. *** P<0.001-Statistically highly significant; **P<0.01-Statistically very 
significant; *P<0.05-Statistically significant; ns - Statistically not significant.
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Graph no: 6. Diagramatic representation of results of effects of HAECMR on LDL levels
STZ-Streptozotocin, GBN-Glibenclamide(10mg/kg;p.o),
LD-lower dose(100mg/kg;p.o) of extract, HD-higher dose(300mg/kg;p.o) of extract.
RESULTS
When compared to STZ treated diabetic control group and Glibenclamide+STZ treated group, 
HAECMR (300mg/kg;p.o) showed significant decrease in LDL levels.
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7.1.4.f. ESTIMATION OF VLDL
Table no: 12. Results of the effects of HAECMR on serum VLDL levels
Group Treatment Serum VLDL (mg/dl)
1st day 48th day
1 Normal control 10.85±0.74 11.84±0.86
2 STZ treated control 11.51±0.63 17.23±0.57
3 Glibenclamide (10mg/kg;p.o) + 
STZ
10.01±0.56 13.67±0.57
4 HAECMR (100 mg/kg;p.o) + STZ 11.02±1.42 14.65±1.6
5 HAECMR (300 mg/kg;p.o) + STZ 10.46±1.02 11.04±0.68*
The values were expressed as Mean ± S.E.M. (n=6) by using ANOVA followed by Dunnet test. 
STZ treated control (Diabetic control) was compared with the vehicle control, extract treated and 
Glibenclamide treated. *** P<0.001-Statistically highly significant; **P<0.01-Statistically very 
significant; *P<0.05-Statistically significant; ns - Statistically not significant
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Graph no: 7. Diagramatic representation of results of effects of HAECMR on VLDL levels
STZ-Streptozotocin, GBN-Glibenclamide(10mg/kg;p.o),
LD-low dose(100mg/kg;p.o) of extract, HD-high dose(300mg/kg;p.o) of extract.
RESULTS
When compared to STZ treated diabetic control group and Glibenclamide+STZ treated group, 
HAECMR (300mg/kg;p.o) showed significant decrease in VLDL levels(p<0.05).
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7.1.4.g. ESTIMATION OF BODY WEIGHT
Table no: 13. Results of the effects of HAECMR on body weight
Grou
p
Treatment Body weight (gm)
0th day 48th day Gain
1 Normal control 178.60±5.7 191.9±5.1 13.30±4.50
2 STZ treated control 180.19±3.32 200.57±4.13 20.38±5.0
3 Glibenclamide (60 µg/kg;p.o) 
+ STZ
189.75±5.1 201.13±5.0 11.38±4.98
4 HAECMR (100 mg/kg;p.o) + 
STZ
183.56±4.2 196.45±3.9 12.89±2.9
5 HAECMR (300 mg/kg;p.o) + 
STZ
180.10±3.9 189.9±7.05* 9.8±4.6*
The values were expressed as Mean ± S.E.M. (n=6) by using ANOVA followed by Dunnet test.
STZ treated control (Diabetic control) was compared with the normal control, extract treated and 
Glibenclamide treated. *** P<0.001-Statistically highly significant; **P<0.01-Statistically very 
significant; *P<0.05-Statistically significant; ns - Statistically not significant.
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Graph no: 8. Diagramatic representation of results of effects of HAECMR on body weight 
before and after treatment of standard and HAECMR
STZ-Streptozotocin, GBN-Glibenclamide(10mg/kg;p.o),
LD-lower dose(100mg/kg;p.o) of extract, HD-higher dose(300mg/kg;p.o) of extract.
RESULTS
When compared with STZ treated diabetic control group, Glibenclamide+STZ group and 
HAECMR (300mg/kg;p.o) showed significant difference in the body weight(p<0.05).
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7.2. DISCUSSION
The management of diabetes without any side effect is still a challenge to the 
medical system. Herbal drugs are prescribed widely because of their effectiveness, fewer side 
effects and relatively low cost. Wide array of plants have demonstrated anti diabetic activity. The 
main active constituents of these plants include alkaloids, terpenoids, Tanins, saponins, 
flavonoids, proteins, gum, carbohydrates, phenolic compounds, terpenoids, amino acids and 
inorganic ions. These affect various metabolic cascades, which directly or indirectly affect the 
level of glucose in the human body.(8)
The colour consistency of the hydroalcoholic extract of Crateva magna  was noted and the 
percentage yield was calculated.
Colour - Brownish green
Consistency - Semisolid
Percentage yield - 10.12 %w/w.
The preliminary phytochemical analysis bark of Crateva magna Root extract showed the 
presence of alkaloids, amino acids, proteins, carbohydrates, flavonoids, glycosides, Tanins, 
terpenoids, saponins, phenolic compounds.
Acute toxicity studies revealed the non-toxic nature of the Hydroalcoholic extract of 
Crateva magna. There was no lethality or any toxic reactions found with high dose (3000 mg/kg) 
till the end of the study. According to the OECD 423 guideline (Acute Oral Toxicity: Acute 
Classic Method), an LD50 dose of 3000 mg/kg and above is consider as unclassified so the 
hydroalcoholic extract of Crateva magna root was found to be safe.
A singular feature of diabetes mellitus is impaired glucose tolerance. This is unmasked by 
an oral glucose tolerance test, in which blood glucose levels are sampled after overnight fasting, 
and then minutes to hours after an oral dose of glucose. In normal persons, blood glucose levels 
rise only modestly, and a brisk pancreatic insulin response ensures a return to normoglycemic 
levels within an hour. In diabetic individuals and in those in a preclinical stage, blood glucose 
rises to abnormally high levels for a sustained period. This may result from an absolute lack of 
pancreatic insulin release or from impaired target tissue response or both.
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The results of glucose intolerance induced by Streptozotocin and comparative delaying 
effect of Crateva magna as well as Glibenclamide in rats during 6 weeks of the experimental 
period. In Glucose Tolerance Test, the Glucose levels were estimated before drug treatment and 
at different intervals thereafter. In the control group, the blood glucose was found to increase 
linearly from basal value of 80.56 mg/dl to 152.20mg/dl in the first 30 minutes. After 60 minutes 
of glucose loading, the blood glucose was increased further. The maximum value of 112.37 mg/dl 
was seen at the 120th minute. Whereas in the extract treated animals, only a little elevation in the 
blood glucose were seen from basal value of 298.88 mg/dl to 369.57 mg/dl in the first 30 
minutes, 388.5 mg/dl in the 60 minutes and 320.7 mg/dl at 90 minutes and maximum glucose 
tolerance was observed at 120th minute. In Glibenclamide treated animals, blood glucose rises to 
350.63 mg/dl from basal value of 275.43 mg/dl in the first 30 minute, 387.5 mg/dl in 60 minutes 
and 250.31 mg/dl at 90 minutes and maximum glucose tolerance was observed at 120th minute.
Mechanisms involved in the development of type 2 diabetes in models of Streptozotocin 
induced Diabetes in adult rodents are increased dietary fat intake is associated with reduced 
activity of pancreatic enzymes, leading to impaired pancreatic function and reduced insulin 
secretion and increased accumulation of lipids in the liver (hepatic stenosis) which results in 
hepatic insulin resistance and increased hepatic glucose output.
The exposure of the liver to large quantities of Streptozotocin leads to rapid stimulation of 
lipogenesis and triglycerides accumulation which in turn contributes to reduced insulin sensitivity 
and hepatic insulin resistance/glucose intolerance. The long-term negative effects can include 
changes in digestion, absorption, plasma hormone levels, appetite, and hepatic metabolism 
leading to the development of insulin resistance , diabetes, obesity, and inevitably cardiovascular 
disease. Because of its lipogenic properties, Streptozotocin can cause glucose malabsorption, 
together with greater elevations in triglycerides and cholesterol compared to other carbohydrates.
At the end of the study (48th day) the hydroalcoholic extracts of Crateva magna root (100 
mg/kg;p.o & 300 mg/kg;p.o) and Glibenclamide (10mg/kg;p.o) treated diabetic groups showed 
statistically significant decrease in blood glucose. So the hydroalcoholic extracts of Crateva 
magna root showed the anti diabetic activity.
In,  diabetes hyperglycemia is accompanied with dyslipidemia represents risk factor for 
coronary heart diseases. The abnormal high level of serum lipids is mainly due to the uninhibited 
actions of lipolytic hormones on the fat depots mainly due to action of insulin. Under normal 
Comparetive study of Antidiabetic and hypolipidemic activity of Crateva magna root & Eugenia jambolana seed and 
its combination in rats . 
Department	of	Pharmacology,	Cherraan  s	College	of	Pharmacy,	Coimbatore Page	66
circumstances, insulin activates the enzyme lipoprotein lipase which hydrolyses triglycerides. 
However, in diabetic state lipoprotein lipase is not associated due to insulin deficiency resulting 
in hypertriglyceridemia and also associated with hyperchlosterolemia due to metabolic 
abnormalities. The dyslipidemia is characterized by increase in total cholesterol, LDL, VLDL, 
triglycerides and HDL.
At the end of the study (48th day), the hydroalcoholic extracts of root of Crateva magna
(100 mg/kg;p.o & 300 mg/kg;p.o) and Glibenclamide (10mg/kg;p.o) treated diabetic groups 
showed statistically significant decrease in total cholesterol, triglycerides, LDL, VLDL levels and 
increase in HDL level. So the hydroalcoholic extracts of Crateva magna showed the 
hypolipidemic activity.
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Eugenia jambolana
7.1.3. ORAL GLUCOSE TOLERANCE TEST (OGTT)
The effect of different doses of Hydroalcoholic extract of Eugenia jambolana seed on oral 
glucose tolerance test in normal rats.
Table no: 14. Results of effects of HAEEJS on OGTT
Treatment SERUM GLUCOSE (mg/ml)
0 min 30 min 60 min 90 min 120 
min
1 Normal control 76.23± 1.68 76.86±1.52 75.90± 1.32 78.32± 1.45 79.70± 
1.27
2 STZ treated diabetic control 294.5± 6.51 294.89±6.45 292.43± 6.53 293.91± 6.72 295.9± 
6.87
3 Glibenclamide(10mg/kg;p.o) 
+ glucose (2 gm/kg;p.o)
288.3± 8.21 290.43±6.56 259.50± 5.92 246.32± 4.54 226.31± 
3.60
4 HAEEJS (100 mg/kg;p.o) + 
glucose (2 gm/kg;p.o)
294.86± 5.75 199.12±5.67 272.30±3.52*
*
267.45± 3.79 246.53± 
3.81
5 HAEEJS (300 mg/kg;p.o) + 
glucose (2 gm/kg;p.o)
294.13± 8.65 198.28±6.26 259.5± 5.53 202.67±3.82*
*
194.81± 
3.51
The values were estimated as Mean+S.E.M (n=6). Extract treated, Glibenclamide treated and 
glucose treated were compared with the vehicle control and STZ treated. **P<0.01-Statistically 
very significant; *P<0.05-Statistically significant; ns - Statistically not significant.
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Graph no: 8. Diagramatic representation of results of the effects of HAEEJS on OGTT
GBN-Glibenclamide(10mg/kg;p.o), GLU-Glucose(2gm/kg;p.o), HD-High dose(300mg/kg;p.o) of 
extract, LD-low dose(100mg/kg;p.o), STZ-Streptozotocin
Results
In Glucose Tolerance Test, the Glucose levels were estimated at 0,30,60,90 and 120 Mins
respectively. The blood sugar level of extract treated groups were found compared to be diabetic 
control and the effects were dose dependant. Group II & IV glucose lowering efficiency between 
90-120 Mins & were comparable to diabetic standard shown in table.
The experiment showed that OGTT measures the ability to use glucose, the bodys main 
source of energy, used to diagnose pre & post diabetes, glucose lowering effects were found after 
oral administration of extracts in rats may be due to the presence of hypoglycaemic flavanoids, 
terpenes or saponins that also requiring further investigation.
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7.1.4. ESTIMATION OF BIOCHEMICAL PARAMETERS
7.1.4.a. Estimation of blood glucose
Table no: 15. Results of the effects of HAEEJS on serum glucose levels
The values were expressed as Mean ± S.E.M. (n=6) by using ANOVA followed by Dunnet test. 
STZ treated control (Diabetic control) was compared with vehicle control extract treated and 
Glibenclamide treated. *** P<0.001-Statistically highly significant; **P<0.01-Statistically very 
significant; *P<0.05-Statistically significant; ns - Statistically not significant
Gro
up
Treatment Serum glucose levels (mg/dl)
0st day 7th day 14th day 21st day
1 Normal control 76.1± 5.52 79.6±1.96 80.3±1.64 83.45±1.72
2 STZ treated diabetic 
control
294.47± 6.33*** 318±8.36*** 372.21±10.299*** 396.40±8.65***
3 Glibenclamide(10 
mg/kg;p.o) + STZ
288.31± 12.04 140.8±5.71** 185.1±7.74** 120.21±7.22**
4 HAEEJS (100 
mg/kg;p.o) + STZ
294±5.75** 199.63±
3.63***
136.52±11.30** 123.20±9.63**
5 HAEEJS (300 
mg/kg;p.o) + STZ
294± 8.65 158.11±5.54*** 132.03±3.35** 95.25±7.84***
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Graph No 9 Diagramatic representation of results of the effects of the HAEEJS on Serum 
glucose levels
STZ- Streptozotocin control,
GBN- Glibenclamide(10mg/kg;p.o)
LD-low dose(100mg/kg;p.o) of extract
HD-high dose(300mg/kg;p.o) of extract.
RESULTS
The blood glucose levels were measured on 0, 7th, 14th, 21st days were showed in Table 
no. 7. When compared with normal control, STZ treated diabetic control group on 0, 7th, 14th and 
21st days showed significant (p<0.001) values. When compared to STZ treated diabetic control 
group, Glibenclamide(10mg/kg;p.o)+STZ treated diabetic group showed significant decrease in 
blood glucose levels on 7th, 14th, 21st day(p<0.05). When compared to STZ treated diabetic 
control group HAEEJS (300mg/kg;p.o) showed significant decrease in blood glucose 
levels(p<0.05).
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7.1.4.b ESTIMATION OF TOTAL CHOLESTEROL
Table no: 16. Results of the effects of HAEEJS on serum total cholesterol levels
Group Treatment Serum total cholesterol (mg/dl)
1st day 48th day
1 Normal control 71.68±5.12 71.24±7.10
2 STZ treated control 73.31±6.35 118.20±16.11
3 Glibenclamide (10 mg/kg;p.o) + 
STZ
68.54±3.10 94.33±10.1
4 HAEEJS (100 mg/kg;p.o) + 
STZ
70.21±6.12 96.08±7.32
5 HAEEJS (300 mg/kg;p.o) + 
STZ
67.19±4.12 75.4±4.59*
The values were expressed as Mean ± S.E.M. (n=6) by using ANOVA followed by Dunnet test. 
STZ treated control (Diabetic control) was compared with the vehicle control, extract treated and 
Glibenclamide treated. *** P<0.001-Statistically highly significant; **P<0.01-Statistically very 
significant; *P<0.05-Statistically significant; ns - Statistically not significant.
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Graph no: 10. Diagramatic representation of the results of the effects of the HAEEJS on 
total cholesterol levels
STZ- Streptozotocin, GBN-Glibenclamide(10mg/kg;p.o),
LD-lower dose(100mg/kg;p.o) of extract, HD-higher dose(300mg/kg;p.o) of extract.
RESULTS
When compared with the STZ treated diabetic control group, Glibenclamide+STZ treated 
group showed significant decrease in total cholesterol levels(p<0.05). When compared with STZ 
treated diabetic group control group and Glibenclamide+STZ treated group HAEEJS
(300mg/kg;p.o) group showed significant decrease in total cholesterol levels(p<0.05).
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7.1.4.c. ESTIMATION OF TRIGLYCERIDES
Table no: 17. Results of the effects of HAEEJS on serum triglyceride levels
Group Treatment Serum triglycerides 
(mg/dl)
1st day 48th day
1 Normal control 54.72±3.61 58.10±4.13
2 STZ treated control 57.57±3.13 85.51±2.29
3 Glibenclamide(10mg/kg;p.o) + 
STZ
50.29±2.91 67.32±3.91
4 HAEEJS (100 mg/kg;p.o) + STZ 55.02±7.2 72.91±8.01
5 HAEEJS (300 mg/kg;p.o) + STZ 52.34±5.22 54.21±3.11*
The values were expressed as Mean ± S.E.M. (n=6) by using ANOVA followed by Dunnet test. 
STZ treated control (Diabetic control) was compared with vehicle control extract treated and 
Glibenclamide treated. *** P<0.001-Statistically highly significant; **P<0.01-Statistically very 
significant; *P<0.05-Statistically significant; ns - Statistically not significant
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Graph no: 11. Diagramatic representation of the results of the effects of the HAEEJS on 
TG levels
STZ-Streptozotocin, GBN-Glibenclamide(10mg/kg;p.o),
LD-lower dose(100mg/kg;p.o) of extract, HD-higher dose(300mg/kg;p.o) of extract.
RESULTS
When compared with the STZ treated diabetic control group, Glibenclamide+STZ treated 
group showed significant decrease in Serum triglycerides level(p<0.05). When compared with 
STZ treated diabetic control group and Glibenclamide+STZ treated group HAEEJS
(300mg/kg;p.o) showed significant decrease in Serum triglycerides level(p<0.05).
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7.1.4.d. ESTIMATION OF HDL
Table no: 18. Results of the effects of HAEEJS on serum HDL levels
Group Treatment Serum HDL (mg/dl)
1st day 48th day
1 Normal control 20.82±3.46 20.13±2.58
2 STZ treated control 18.59±4.26 30.21±3.41
3 Glibenclamide(10mg/kg;p.o) + 
STZ
20.17±3.70 30.34±2.69
4 HAEEJS (100 mg/kg;p.o) + STZ 15.52±4.71 30.71±2.90
5 HAEEJS (300 mg/kg;p.o) + STZ 17.61±3.82 34.26±3.06*
The values were expressed as Mean ± S.E.M. (n=6) by using ANOVA followed by Dunnet test. 
STZ treated control (Diabetic control) was compared with vehicle control, extract treated and 
Glibenclamide treated. *** P<0.001-Statistically highly significant; **P<0.01-Statistically very 
significant; *P<0.05-Statistically significant; ns - Statistically not significant
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Graph no: 12. Diagramatic representation of results of HAEEJS on HDL
STZ-Steptozotocin, GBN-Glibenclamide(10mg/kg;p.o),
LD-lower dose(100mg/kg;p.o) of extract, HD-higher dose(300mg/kg;p.o) of extract.
RESULTS
When compared to STZ treated diabetic control group and Glibenclamide+STZ treated group, 
HAEEJS (300mg/kg;p.o) showed significant increase in HDL levels(p<0.05).
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7.1.4.e. ESTIMATION OF LDL
Table no: 19. Results of the effects of HAEEJS on serum LDL levels
Group Treatment Serum LDL (mg/dl)
1st day 48th day
1 Normal control 39.81±5.14 40.87±3.82
2 STZ treated control 43.67±4.69 69.26±12.0
3 Glibenclamide(10mg/kg;p.o) + 
STZ
38.01±5.14 47.97±8.32
4 HAEEJS (100 mg/kg;p.o) + STZ 42.75±2.58 50.03±3.51
5 HAEEJS (300 mg/kg;p.o) + STZ 39.72±2.65 40.71±0.03*
The values were expressed as Mean ± S.E.M. (n=6) by using ANOVA followed by Dunnet test. 
STZ treated control (Diabetic control) was compared with the vehicle control, extract treated and 
Glibenclamide treated. *** P<0.001-Statistically highly significant; **P<0.01-Statistically very 
significant; *P<0.05-Statistically significant; ns - Statistically not significant.
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Graph no: 13. Diagramatic representation of results of effects of HAEEJS on LDL levels
STZ-Streptozotocin, GBN-Glibenclamide(10mg/kg;p.o),
LD-lower dose(100mg/kg;p.o) of extract, HD-higher dose(300mg/kg;p.o) of extract.
RESULTS
When compared to STZ treated diabetic control group and Glibenclamide+STZ treated group, 
HAEEJS (300mg/kg;p.o) showed significant decrease in LDL levels.
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7.1.4.f. ESTIMATION OF VLDL
Table no: 20. Results of the effects of HAEEJS on serum VLDL levels
Group Treatment Serum VLDL (mg/dl)
1st day 48th day
1 Normal control 10.81±0.73 11.62±0.87
2 STZ treated control 11.53±0.61 16.72±0.53
3 Glibenclamide (10mg/kg;p.o) + 
STZ
10.06±0.51 13.98±0.56
4 HAEEJS (100 mg/kg;p.o) + STZ 11.12±1.41 13.96±1.7
5 HAEEJS (300 mg/kg;p.o) + STZ 10.45±1.03 11.10±0.69*
The values were expressed as Mean ± S.E.M. (n=6) by using ANOVA followed by Dunnet test. 
STZ treated control (Diabetic control) was compared with the vehicle control, extract treated and 
Glibenclamide treated. *** P<0.001-Statistically highly significant; **P<0.01-Statistically very 
significant; *P<0.05-Statistically significant; ns - Statistically not significant
Comparetive study of Antidiabetic and hypolipidemic activity of Crateva magna root & Eugenia jambolana seed and 
its combination in rats . 
Department	of	Pharmacology,	Cherraan  s	College	of	Pharmacy,	Coimbatore Page	80
Graph no: 14. Diagramatic representation of results of effects of HAEEJS on VLDL levels
STZ-Streptozotocin, GBN-Glibenclamide(10mg/kg;p.o),
LD-low dose(100mg/kg;p.o) of extract, HD-high dose(300mg/kg;p.o) of extract.
RESULTS
When compared to STZ treated diabetic control group and Glibenclamide+STZ treated group, 
HAEEJS (300mg/kg;p.o) showed significant decrease in VLDL levels(p<0.05).
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7.1.4.g. ESTIMATION OF BODY WEIGHT
Table no: 21. Results of the effects of HAEEJS on body weight
Grou
p
Treatment Body weight (gm)
0th day 48th day Gain
1 Normal control 178.61
±5.6
190.8±5.2 12.19±4.52
2 STZ treated control 180.18
±3.31
201.67±4.14 21.49±5.01
3 Glibenclamide (60 µg/kg;p.o) + STZ 189.55
±5.11
200.10±5.01 10.55±4.99
4 HAEEJS (100 mg/kg;p.o) + STZ 183.65
±4.21
195.43±3.91 11.78±2.91
5 HAEEJS (300 mg/kg;p.o) + STZ 180.41
±3.91
188.7*±7.07 8.29*±4.60
The values were expressed as Mean ± S.E.M. (n=6) by using ANOVA followed by Dunnet test. 
STZ treated control (Diabetic control) was compared with the normal control, extract treated and 
Glibenclamide treated. *** P<0.001-Statistically highly significant; **P<0.01-Statistically very 
significant; *P<0.05-Statistically significant; ns - Statistically not significant.
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Graph no: 15. Diagramatic representation of results of effects of HAEEJS on body weight 
before and after treatment of standard and HAEEJS
STZ-Streptozotocin, GBN-Glibenclamide(10mg/kg;p.o),
LD-lower dose(100mg/kg;p.o) of extract, HD-higher dose(300mg/kg;p.o) of extract.
RESULTS
When compared with STZ treated diabetic control group, Glibenclamide+STZ group and 
HAECMR (300mg/kg;p.o) showed significant difference in the body weight(p<0.05).
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In addition to the above test we have calculated % fall in blood glucose level for 3 samples 
namely 1. Crateva magna, 2. Eugenia jambolana, 3. 1:1 mixture of these two and consequently 
ED 50 values for these 3 samples were obtained graphically (Refer below Table 22,23 and 24 
graph no 16)
Table No 22 Crateva magna root (HAECMR)
Doses in 
mg/kg,p.o
0 Day 7th Day 14th Day 21st Day % age 
fall 
after 
21 days
100 298.0±12.31** 248.63±7.33*** 220.52±11.30** 185.20±9.63 30%
200 310.44±6.25 268.0±7.62** 212.0±6.85 175.40±5.92 32%
300 298.88±3.52** 235.11±5.50*** 210.03±3.35** 185.71±7.84 
***
44%
400 298.12±5.98 210.45±6.21 188.74±4.35 119.22±6.25 60%
Table No 23 Eugenia jambolana seed (HAEEJS)
Doses in 
mg/kg,p.o
0 Day 7th Day 14th Day 21st Day % age fall 
after 21 
days
50 294.0±3.18 252.58±3.67 241.80±4.21 229.32±4.13 22%
100 294.0±5.12 199.0±3.63*** 185.38±2.15*** 170.60±4.45 42%
200 294.0±6.18 182.30±4.54 152.88±4.32 123.48±5.42 58%
300 294.0±6.78 158.0±3.84*** 136.30±2.74*** 95.25±3.75 68%
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Table No 24 Crateva magna and Eugenia jambolana 1:1 combination 
(HAECOM)
Doses in 
mg/kg,p.o
0 Day 7th Day 14th Day 21st Day % age fall 
after 21 
days
50 295.15±5.12 280.15±3.62 257.23±4.18 236.15±5.24 20%
100 294.25±4.82 280.32±5.62 249.45±3.14 182.45±4.27 38%
200 296.75±3.98 274.34±4.67 221.27±5.51 136.50±5.02 54%
300 295.65±5.08 271.67±3.82 196.78±4.64 103.48±3.14 65%
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Graph No 16 
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Dose Response Curve
Graph No 16  shows the DRC of Crateva magna, Eugenia jambolana and 1:1 mixture of these 
two each at 4 dose level.
DRC of Crateva magna is shifted to the right hand side as compared to other 2 graphs. The DRC 
of  Eugenia jambolana shifted to the left hand side which indicates Eugenia jambolana is most 
potent sample for its anti diabetic effect as compared to other two samples. The DRC of the 
mixture of these two seems to be comparatively more potent than Crateva magna alone as its 
graph has been shifted to the left hand side away from the Crateva magna graph and it lies very 
close to Eugenia graph. 
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8. SUMMARY AND CONCLUSION
The Hydroalcoholic extract of root of Crateva magna in a dose of 300mg/kg;p.o showed 
statistically significant antidiabetic and hypolipidemic activity. 
The Hydroalcoholic extract of seed of Eugenia jambolana in a dose of 300mg/kg;p.o showed 
statistically significant antidiabetic and hypolipidemic activity. 
The extract showed significant activity against Streptozotocin induced Diabetes in rats 
when compared with that of standard drug Glibenclamide, In percentage inhibition graph ED 50 
dose of Crateva Magana which causes 50 % inhibition of the blood glucose level is found to 340 
mg p.o and that of Eugenia jambolana 150 mg p.o and that of 1:1 mixture of these two is found to 
170 mg.
Although the mixture does not seem to be more potent than Eugenia alone definitely this 
combination found to superior than Crateva magna alone.
We understand as per the literature survey Crateva magna reduces the blood sugar level by 
inhibiting by enzyme alpha glucosidase therefore Eugenia jambolana potentiates the antidiabetic 
effect of Crateva magna.
The extract showed significant activity against Streptozotocin induced Diabetes in rats 
when compared with that of standard drug Glibenclamide.
In conclusion, the results of the present study reveals the Antidiabetic and hypolipidemic 
activity against diabetes in rats.
Further investigation is underway to determine the exact phytoconstituents in the extract 
that are responsible for its Antidiabetic and hypolipidemic activity.
We recommend who so ever wants to continue this work to try upon other antidiabetic herbal 
drugs and its mixture with Crateva magna and in this way to introduce into the market newer and 
safer poly herbal anti diabetic formulation. Then only these findings will act as a boon for the 
humanity suffering from diabetics.
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